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Abstract 
 
The use of Computed Tomography (CT scans) in medical diagnosis delivers radiation 
doses to patients higher than those from conventional medical imaging. Lack of optimized 
protocols could be an additional source of increased radiation dose to patients.  CT scans 
account for about 20 % of the total medical X-ray procedures performed in the world wide. 
Chest CT scan is one of the most frequent procedures. 
In Palestine, currently there are about 28 CT scanners, 24 of them in the West Bank, 4 
Scanners in Gaza Strip. In the case of female patients, chest CT scan will deliver a 
considerably high dose to a radiosensitive breast. This work aims at the assessment of 
breast dose and associated lifetime attributable risk LAR from chest CT scans performed 
on 200 female patients in 10 Palestinian hospitals in the West Bank and Gaza Strip.  
Dose estimation was performed theoretically using commercially available software based 
on Monte Carlo simulation of the human body with tissue equivalent phantoms of all ages 
and sizes. used BEIR VII Phase 2 modeling to accurately assessment internal organ dose 
lifetime attributable cancer risk (LAR).  
All relevant input data were collected in a data base including patients such as data age, 
weight, and body mass index BMI; and data on CT scanners such as Computed 
Tomography Dose Index CTDI, Dose Length Product DLP, mAs, and kVp. It was found 
that the radiation dose resulting from the same exam varies widely between different 
hospitals, depending on the parameters used and the type of scanner.  
For all patients, the effective dose from chest CT scan per exam varies from 3 to 14.7 mSv 
with a mean of 7 mSv, while the breast dose varies from 6.5 to 17.5 mGy per procedure, 
with a mean of 15 mGy. The patient’s radiation lifetime attributable breast cancer risk 
LAR estimated in Palestine in younger female is 0.00042 % or 1 in 2645 for 15 - 39 years 
and in older female is 0.00014 % or 1 in 10,473 for 40 - 60 years, The International 
commission on radiological protection recommendation (ICRP) does should not exceed 45 
mGy, and the lifetime attributable breast cancer risk for younger and older female patients 
should not exceed 0.00865% and 0.00160%, respectively. 
Results indicate that radiation dose to glandular breast tissue generally decreases with the 
use of suitable exposure scanning parameters. 
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Chapter One: 
_____________________________________________________ 
Introduction 
Medical Computed Tomography   
and Radiation Exposure Definition  
 
1.1 Historical Background 
Computed tomography CT scan is an imaging technique which produces a digital 
tomographic image from diagnostic X-ray. The basic principle of CT scan involve 
digitizing an image received from a slit scan projection of the patient’s body and then back 
projecting the image thought mathematical algorithms (Julian Simpson, 1999). 
The invention of CT scan has been credited to Godfrey N. Hounsfield for his work in 
1970-71, although preliminary work was done by Oldendrof in 1961 and Alan Cormack in 
1963, they won a nopel price 1979 for their work to develop this type of modality of 
imaging technique, and all three based their work on the investigations of the Austrian 
mathematician J.Radon, who proved in 1917 (Julian Simpson, 1999). 
Modern CT scan units are capable of diverse modes (helical and spiral) much more 
complex than simple axial scanning.  Since the introduction of helical CT scan in 1990, the 
technology of CT scanners has changed extremely. The development of multi slice systems 
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in 1998 has accelerated the implementation of many new CT scan examinations (Julian 
Simpson, 1999).  
The number of slices, acquired per axial rotation has increased, with 16, 64, 128 and 256-
slice systems now available. In these days, a larger detector arrays and axial coverage per 
rotation will be commercially available, with results from a 512-slice scanner having 
already, increased use of multiphase exams, vascular and cardiac exams, perfusion 
imaging, and screening exams primarily the heart, chest, and colon, but also self-referred 
whole body screening exams. (Julian Simpson, 1999). 
1.2 Radiation dose for CT scan and related risks 
 
The CT scan imaging plays a necessary role in modern medicine, its rapid adoption has 
resulted in a dramatic increase in the average medical radiation exposure because this 
technique gives high radiation dose to patients in comparison with other images modalities 
based on ionizing radiation. For example, one Chest CT scan examination gives radiation 
more than 400 times the dose delivered by a conventional Chest X-ray examination (Keith 
J. Strauss and Marilyn J. Goske, 2010). 
CT scan represents only 20 % of the total number of medical X-ray procedures in the 
worldwide. This high dose procedure contributes as 43 % of the annual collective doses 
from all medical X-ray examinations to the population see Table 1.1.  As compared with 
the previous United Nations scientific committee (UNSCEAR) report six years, see Table 
1.1, the collective dose has grown to a factor of about 2.5 (Keith J. Strauss and Marilyn J. 
Goske, 2010). 
Table 1.1: Global average relative frequency and collective dose of various types of   
diagnostic X-ray procedures (all ages, both gender) (UNSCEAR, 2010) 
X-ray examination Relative frequency (%) Collective dose (%) 
Chest examinations (PA, 
lateral, others) 
40 13.3 
Limb and joint 8.4 <1 
Skull 3.2 4.2 
Abdomen, pelvis, hip 5.2 4.5 
Spine 7.4 4.2 
Fluoroscopic studies 4.8 14.5 
Mammography 3.6 <1 
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X-ray examination Relative frequency (%) Collective dose (%) 
Computed tomography 6.3 43.2 
Angiography 
fluoroscopy-guided 
interventional procedures 
<1 6.1 
Other X-ray medical 
imaging procedures 
3 11 
Dental procedures 13 <1 
 
Patients have benefited from the rapid diagnoses made possible by CT scan and from its 
value for monitoring chronic disease. However, there is an increasing concern regarding 
the risks of this exposure to radiation. It is well established that radiation can be harmful 
and has both stochastic and deterministic effects (such as hair loss, skin burns, and cell 
death, which are dose dependent but do not occur below a threshold of 150-200 mSv) 
(Keith J. Strauss and Marilyn J. Goske, 2010). 
It is difficult to assess a safe level of radiation exposure. The typical estimated dose 
associated with proper use of CT scan is in the range of 2-10 mSv, in which deterministic 
effects are not normally a concern the induction of cancer by radiation is a probabilistic 
(stochastic) effect, not a deterministic effect. That is, higher radiation doses are associated 
with a higher likelihood of carcinogenesis, but even low doses of radiation could 
potentially induce carcinogenesis (Radiology Rounds, 2003). 
Why do CT scan use high radiation dose? That use of many photons series of exposures 
rather than the single exposure of conventional projection radiography, and the loss of self-
regulation inherent in conventional radiography afforded by the use of film (P Dawson, 
2004). The reason for this lies in the interposition technique used to reconstruct the image. 
To reconstruct the highest slice, this factor may contribute up to 10 % increase in the 
effective dose (Claire Louise chappie, 2008). 
CT scan risk is determined using either direct measures of dose, such as organ dose, or a 
weighted measure of radiation dose taking into account various organ doses and 
sensitivities (effective dose). The risk of radiation induced malignancies from a single CT 
scan exposure is difficult to assess. Optimization of CT scan procedures is also important 
to secure a dose as low as reasonable achievable (ALARA Principle) (Claire Louise 
chappie, 2008). 
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The international commission on radiation units and measurements (ICRU) states that to 
"assess the risk from stochastic and deterministic effects from medical X-ray imaging, it is 
necessary to know the organ or tissue doses, the dose distribution and the age and gender 
of the patients, the quantities and units to be used in medical x-ray imaging as well as 
methods for patient dose estimation and measurements are given in ICRU report 74", the 
unit is the gray (Gy) (Dan E. Ware, MD Walter Huda, 1999). CT scan doses may be 
estimated from computed tomography dose index (CTDI) and Dose length product (DLP) 
(P Dawson, 2004). Doses can also be measured directly by placing thermoluminiscent 
dosimeters (TLD) or diodes on the patients during the procedures, and indirectly by using 
simulation software such as used in this study; Monte Carlo Simulation Software (Dan E. 
Ware, MD Walter Huda, 1999). 
The investigation of effective doses and organ doses to individual patients can be done by 
taking into account the individual technique factors, as well as the physical size of the 
patients underwent CT scan procedures (Dan E. Ware, MD Walter Huda, 1999). A 
comparison of the selected technique factors and the corresponding patient doses will help 
to determine whether these CT scan radiation doses to patients are as low as reasonably 
achievable (ALARA Principle), as required by the international commission on 
radiological protection (ICRP, 2007). 
 
1.3 CT scan situation in Palestine 
 
Radiation protection knowledge in Palestine is weak, radiologists and radiographers in 
Palestine don’t have a clear strategy about the use of medical radiation. So this study 
comes to put plan on how to use new statistical approaches and procedure to estimate 
effective dose and organ dose for medical examination in Palestine. In special 
consideration, estimation of female Chest CT scans dose and assessment of radiation breast 
cancer risk. 
According to Palestinian Health Ministry annual report, Palestinian population is estimate 
to about 4, 485,400 people at the end of 2013. The population is divided between the West 
Bank about 2.8 million (61.4%) and about 1.7 million (38.6 %) in Gaza Strip (PHIC, 
2013).   
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The hospital count in Palestine is about 80 hospitals and 96 medical center are locate in the 
West Bank (63 %) and these hospitals have about 844 beds (PHIC, 2013), Currently there 
are about 28 CT scan in Palestine, The 24 CT scanners in the West Bank, and 4 CT 
Scanners in Gaza strip in 2015. Nearly approximately 88,200 CT scan examinations in 
West Bank in 2015. According to the General Administration of health policy and planning 
(Palestinian Health Information Center, 2015), this constitutes about 70 % of all medical 
CT scan procedures performed in Palestine hospitals government, In addition, it remains 
about 30 % of CT in private hospitals. 
Accordingly, the total CT scan examination in Palestine approximately 110.000 CT scans 
examinations (Palestinian Medical Engendering Units, 2015). 
Despite the fact of the many benefits of CT scan, the risks from CT scan ionization is 
increasing and cause many effects and syndrome, stochastic effect such as cancer from CT 
scan. Cancer is considered the second death causative in Palestine for about 13.3%, and it 
is increasing annually for noticed (PHIC, 2013). 
 
1.4 Problems statement 
 
This research is interested to study of medical radiation exposure in Palestine, which 
should be taken to give the diagnostic information in the best way with minimum x-ray 
dose. Increased use of this high dose procedure has been of great concern globally because 
of the high possibility of inducing undesired health effects, such as induction of cancer in 
patients. The radiation dose must be known to estimate the patient’s potential risk from 
radiation and to weight the risk against the benefits of scanning. In addition, most radiation 
regulatory agencies require the measurement or estimation of radiation dose to the patient 
from medical x-ray units.  
The ICRP has thus warned against CT scan in report 87 stating that: ―The absorbed dose to 
tissue from CT scan (10 to 100 mGy) can often approach or exceed the levels known to 
increase the probability of cancer‖ (Keith J. Strauss and Marilyn J. Goske, 2010). 
The aim of this study is to analyze the factors that affect in medical radiation doses and 
estimate the Chest effective dose and Breast organ dose by Monte Carlo simulation 
software, and to calculate breast cancer risk from Chest CT scan by the Seventy Biological 
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effects of Ionizing Radiation Committee Phase Two (BEIR VII Phase 2) to calculate 
Lifetime attributable breast cancer risk in Chest CT scan. 
 
1.5 Objectives 
 
The objectives of this study are to find out the effective dose, breast organ dose and cancer 
risk from Chest CT scan from in the West bank and Gaza strip of Palestine; in order to get 
appropriate recommendations to limit it’s cancer risk and to decrease its breast organ 
absorption radiation.  
The study will try to achieve the following objectives: 
 Investigate doses from Chest CT scan examinations of female patients and to 
compare the doses with international standards as provided in dose reference levels 
(DRLs). 
 
 Measure and evaluate the organ and effective dose in female patients during breast 
organs CT scanning by Chest CT scan software. 
 
 Calculate and assess the lifetime attributable cancer risk in female patients during 
breast CT scanning by Chest CT scan model. 
 
 Establishing Chest dose reference levels (DRLs) for each facility as a part of 
quality assurance program. 
 
 Improve the radiological techniques to assure that radiation dose to female patient 
comply with the as low as reasonable achievable (ALARA principles). 
 
 
 Provide a protocol for the optimal exposure factors that can give dose without 
exceeding dose reference levels (DRLs) with high image quality. 
 
 
 
7 
 
 
 
 
 
 
 
 
 
Chapter Two: 
______________________________________________________________ 
Theoretical Background: 
 
2.1  Principles of Computed Tomography 
 
The CT scanner is a device using an X-ray source which can be used to give precise 
information on the attenuation properties of a thin sectional volume of the body. 
The general structure of CT scan equipment can be divided in three principle elements: 
1. The Data Acquisition and Transfer system, which encompasses the gantry, the 
patient’s table, the power distribution unit and the data transfer unit (Cattin, 2010). 
 
2. The computing system is installed in separate room, making it possible for the 
operator (Radiographer) to control the acquisition process, introducing patient data 
and selecting several acquisition parameters such as the kVp , mA values the 
protocol is going to use (Cattin, 2010). Also there is another operator’s console for 
editing and post processing is also necessary, so it possible to analyze and review 
previous exam data, without interfering with the current examinations taking place 
(Cattin, 2010). 
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3. The image reconstruction system: receives the X-ray transmission data information 
from the data transfer unit, in a digital format. This gathered data is then corrected 
using reconstruction algorithms and later stored (Cattin, 2010), Figure 2.1 shows 
CT scanners. 
 
2.1.1  CT scan Gantry: 
Moveable frame that contains the x-ray tube including collimators and filters, detectors, 
data acquisition system (DAS), rotational components including slip ring systems and all 
associated electronics such as gantry angulation motors and 6 positioning laser lights 
(Bushong, Stewart, 1993). A CT scan gantry can be angled up to 30 degrees toward a 
forward or backward position. Gantry angulation is determined by the manufacturer and 
varies among CT scan systems. The opening through which a patient passes is referred to 
as the gantry aperture. Gantry aperture diameters generally range from 50-85 cm. Lasers or 
high intensity lights are included within or mounted on the gantry. The lasers or high 
intensity lights serve as anatomical positioning guides that reference the center of the axial, 
coronal, and sagittal planes (Bushong, Stewart, 1993), Figure 2.1 shows CT scan gantry. 
 
Figure 2.1:  CT scanner Gantry 
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2.1.2   X -ray Tube, Collimation and Filtration: 
 
CT scan procedures facilitate the use of large exposure factors, (high mA and kVp values) 
and short exposure times. CT scan systems produce x-radiation continuously or in short 
millisecond pulses. CT scan x-ray tubes must possess a high heat capacity which is the 
amount of heat that a tube can store without operational damage to the tube. CT scan 
systems utilize x-ray tubes that have a heat capacity of approximately 3.5 to 5 million heat 
units (MHU). Many CT scan x-ray tubes utilize a combination of oil and air cooling 
systems to eliminate heat and maintain continuous operational capabilities (Bushong, 
Stewart, 1993). A CT scan x-ray tube anode has a large diameter with a graphite backing. 
The large diameter backed with graphite allows the anode to absorb and dissipate large 
amounts of heat. CT scan tubes utilize a bigger filament than conventional radiography x-
ray tubes. The use of a bigger filament increases the size of the effective focal spot 
decreasing the anode or target angle decreases the size of the effective focal spot. CT scan 
tubes employ a target angle approximately between 7 and 10 degrees. The decreased anode 
or target angle 7 also helps elevate some of the effects caused by the heel effect. CT scan 
can compensate any loss of resolution due the use of larger focal spot sizes by employing 
resolution enhancement algorithms such as bone or sharp algorithms, targeting techniques, 
and decreasing section thickness (Bushong, Stewart, 1993).  
In CT collimation of the x-ray beam includes tube collimators, a set of pre patient 
collimators and post patient or pre detector collimators. Some CT scan systems utilize this 
type of collimation system while other does not. The tube or source collimators are located 
in the x-ray tube and determine the section thickness that will be utilized for a particular 
CT scanning procedure. A second set of collimators located directly below the tube 
collimators maintain the width of the beam as it travels toward the patient. A final set of 
collimators called post-patient or pre-detector collimators are located below the patient and 
above the detector (Bushong, Stewart, 1993) Figure 2.2 shows image acquisitions in CT 
scan. 
The primary responsibilities of this set of collimators are to insure proper beam width at 
the detector and reduce the number of scattered photons that may enter a detector. There 
are two types of filtration utilized in CT scan. Mathematical filters such as bone or soft 
tissue algorithms are included into the CT scan reconstruction process to enhance 
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resolution of a particular anatomical region of interest. Inherent tube filtration and filters 
made of Aluminum or Teflon are utilized in CT scan to shape the beam intensity by 
filtering out low energy photons that contribute to the production of scatter. Special filters 
called "bow-tie" filters absorb low energy photons before reaching the patient. Heavy 
filtration of the x-ray beam results in a more uniform beam. The more uniform the beam, 
the more accurate the attenuation values or CT scan numbers are for the scanned 
anatomical region (Bushong, Stewart, 1993) Figure 2.2 shows Image acquisitions in CT 
scan. 
 
Figure 2.2:  Image acquisitions in CT scan. 
 
 
2.1.3    Detectors: 
 
When the x-ray beam travels through the patient, it is attenuated by the anatomical 
structures it passes through. The image receptors that are utilized in CT scan are referred to 
as detectors. The CT scan process essentially relies on collecting attenuated photon energy 
and converting it to an electrical signal, which will then be converted to a digital signal for 
computer reconstruction (Wolbarst, Anthony B, 1993). The two types of detectors utilized 
in CT scan systems are scintillation or solid state and xenon gas detectors Figure 2.3 shows 
scintillation and xenon gas detector image acquisition in CT scan. Scintillation detectors 
utilize a crystal that fluoresces when struck by an x-ray photon which produces light 
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energy. A photodiode is attached to the scintillation portion of the detector. The 
photodiode transforms the light energy into electrical or analog energy. The most 
frequently used scintillation crystals are made of Bismuth Germinate (Bi4Ge3012) and 
Cadmium Tungstate (CdW 04) Figure 2.3 shows scintillation and xenon gas detector 
image acquisition in CT scan (Wolbarst, Anthony B, 1993). 
 
 
Figure 2.3: Scintillation and xenon gas detector image acquisition in CT scan 
 
The second type of detector utilized for CT scan imaging system is a gas detector. The gas 
detector is usually constructed utilizing a chamber made of a ceramic material with long 
thin ionization plates usually made of Tungsten submersed in xenon gas. The long thin 
tungsten plates act as electron collection plates. When attenuated photons interact with the 
charged plates and the xenon gas ionization occurs. The ionization of ions produces an 
electrical current. Xenon gas is the element of choice because of its ability to remain stable 
under extreme amounts of pressure. The term detector refers to a single element or a single 
type of detector used in a CT scan system. The term detector array is used to 9 describe the 
total number of detectors that a CT scan system utilizes for collecting attenuated 
information (Wolbarst, Anthony B, 1993). 
The path that an x-ray beam travels from the tube to a single detector is referred to as a ray 
after the x-ray beam passes through the object being scanned, the detector samples the 
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beams intensity. The detector reads each ray and measures the resultant beam attenuation. 
The attenuation measurement of each ray is termed a ray sum. A complete set of ray sums 
is referred to as a view or projection. It takes many views to create a computed tomography 
image (Morgan, Carlisle L, 1983).  
The more photons collected, the stronger and more accurate the detector signal. This is 
essential for accurate image reconstruction. The dynamic range determines the ability of a 
detector to detect and differentiate a wide range of x-ray intensities. Dynamic range of a 
detector describes the range of x-ray exposures at the detector to which the system can 
respond without saturation and produce satisfactory gray-scale images. CT scan systems 
have the ability to respond to 1,000,000 x-ray intensities at approximately 1,100 views per 
second (Morgan, Carlisle L, 1983). 
 
2.1.4   Data Acquisition System (DAS): 
Once the detector generates the analog or electrical signal it is directed to the data 
acquisition system (DAS). The analog signal generated by the detector is a weak signal and 
must be amplified to further be analyzed. Amplifying the electrical signal is one of the 
tasks performed by the data acquisition system (DAS) (Seeram, Euclid, 1994). The DAS is 
located in the gantry right after or above the detector system. In some modern CT scan 
scanning systems the signal amplification occurs within the detector itself. Before the 
projection or raw data, which is currently in the form of an electrical or analog signal, goes 
to the computer it must be converted to digital information.  
The computer does not understand analog signals therefore; the information must be 
converted to digital information. This task is accomplished by an analog to digital 
converter which is an essential component of the DAS.  
The digital signal is transferred to an array processor. The array processor solves the 
statistical information using algorithmic calculations essential for mathematical 
reconstruction of a CT scan image. An array processor is a specialized high speed 
computer designed to execute mathematical algorithms for the purpose of reconstruction 
(Berland, Lincoln L, 1987), the array processor solves reconstruction mathematics faster 
than a standard microprocessor. It is important to note that special algorithms may require 
several seconds to several minutes for a standard microprocessor to compute. Recently, 
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processors that compute CT scan reconstruction mathematics faster than an array processor 
have been utilized to solve reconstruction mathematics essential to the development of CT 
scan fluoroscopy. The term image or reconstruction generator is used to describe this type 
of computer (Berland, Lincoln L, 1987). 
 
2.1.5    CT scan Table : 
 
CT scan tables or couches should be made with a material that will not cause artifacts 
when scanned. Many CT scan tables or couches are made of a Carbon fiber material. 
Various attachments are available for different types of scanning procedures. Attachments 
for direct coronal scanning and therapy planning are commonly used in many CT scan 
departments (Bushong, Stewart, 1993). 
 
2.1.6   Power Distribution Unit: 
 
The power Distribution unit supplies power to the gantry, the patient’s table and the 
computers of the Computing System (Bushong, Stewart, 1993). 
 
2.2.1    CT scan imaging technique: 
 
Early machines had an x-ray tube and detector that moved in precise alignment on opposite 
sides of the patient to make each pass. The size of these machines allowed only heads to be 
scanned. After one pass, the gantry containing the tube and detector was 11 rotated 1° and 
the next pass was taken. After data for 180 passes were recorded, the image was 
reconstructed. A complete scan took about 4 minutes. CT scan units use an array of 
detectors and a fan shaped beam that covers the whole width of the patient. The scan time 
is reduced to a few seconds. Figure 2.4 shows the early evolution of the scanning 
techniques (Glassberg, 2013). 
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Figure 2.4: The scanning techniques used in the first four generations of CT scanners. 
 
CT scan machines all of the electrical connections are made through slip rings. This allows 
continuous rotation of the gantry and scanning in a spiral as the patient moves through the 
machine (Glassberg, 2013). Interpolation in the direction of the axis of rotation (the z axis) 
is used to perform the reconstruction for a particular value of z. This is called spiral CT 
scan or helical CT scan. Array detectors are now used to fill in the space between the 
spirals. Table 2.1 shows how scanners have improved since they were first introduced. 
Spiral CT provides p(x, y, z), and the images can be displayed in three dimensions 
(Glassberg, 2013). 
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Table 2.1: The evolution of typical values for high performance CT machines 
(Glassberg, 2013). 
Feature 1972 1980 1990 2000 
Minimum scan time 300 s 5-10 s 1-2 s 0.3-1 s 
Data per 360 ° scan 57.6 kB 1 MB 2 MB 42 MB 
Data per spiral scan - - 24-48 MB 200-500 MB 
Image matrix 80 x 80 256 x 256 512 x 512 512 x 512 
Power (kW) 2 10 40 60 
Slice thickness (mm) 13 2-10 1-10 0.5-5 
Spatial resolution (Line 
pair cm-1) 
3 8-12 10-15 12-25 
 
2.2.2    Chest CT scans examination: 
 
CT scanning of the Chest uses special equipment to obtain multiple cross sectional images 
of the organs and tissues of the Chest CT scan produces images that are far more detailed 
than a conventional Chest x-ray. CT scan is especially useful because it can simultaneously 
show many different types of tissue including the lungs, heart, bones, soft tissues, muscle 
and blood vessels (Glassberg, 2013), Using a variety of techniques, including adjusting the 
radiation dose based on patient size and new software technology, a growing fraction of 
the population is exposed to low dose ionizing radiation from CT scan. Data extrapolated 
from atomic bomb survivors and other populations exposed to low dose ionizing radiation 
suggest that CT scan associated radiation may increase an individual lifetime risk of 
developing cancer. Because this topic has recently attracted the attention of both the 
scientific community and the general public, it has become increasingly important for 
physicians to understand the cancer risk associated with CT scan (Sarma A et al, 2012). 
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2.3    Radiation Quantities and Units 
2.3.1    Radiation Quantities: 
There are many different physical quantities that can be used to express the amount of 
radiation delivered to a human body. Generally, there are advantages and applications as 
well as disadvantages and limitations for each of the quantities. There are two types of 
radiation quantities: those that express the concentration of radiation at some point, or to a 
specific tissue or organ, and there are also quantities that express the total radiation 
delivered to a body (Perry Sprawls, May 1993) Figure 2.5 shows radiation quantities. 
 
 
Figure 2.5: Radiation quantities 
 
2.3.2   Radiation Units: 
Throughout the course of history there have been many different systems of units 
developed to express the values of the various physical quantities. In more recent times the 
metric system has gradually replaced some of the other more traditional or classic systems, 
It his is also true for the units used for many of our radiation quantities (Perry Sprawls, 
May 1993). 
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2.3.3     Exposure: 
 
Exposure is the quantity most commonly used to express the amount of radiation delivered 
to a point. The conventional unit for exposure is the roentgen (R). and the SI unit is the 
coulomb per kilogram of air (C/kg):  
1 R = 2.58 x 10
-4  
C/kg 
1 C/kg = 3876 R 
 
The specific effect used to measure exposure is the ionization in air produced by the 
radiation. Exposure is generally measured by placing a small volume of air at the point of 
measurement and then measuring the amount of ionization produced within the air. 
Exposure is a quantity of radiation concentration. For specific photon energy, exposure is 
proportional to photon concentration (Perry Sprawls, May 1993). 
 
2.3.4   Absorbed dose: 
 
Absorbed dose is the quantity that expresses the concentration of radiation energy absorbed 
at a specific point within the body tissue. Since an x-ray beam is attenuated by absorption 
as it passes through the body, all tissues within the beam will not absorb the same dose 
Figure 2.6 shows absorbed Dose. The absorbed dose will be much greater for the tissues 
near the entrance surface than for those deeper within the body. Absorbed dose is defined 
as the quantity of radiation energy absorbed per unit mass of tissue (Perry Sprawls, May 
1993). The conventional unit for absorbed dose is the rad. which is equivalent to 100 ergs 
of absorbed energy per (g) of tissue. The SI unit is the gray (Gy), which is equivalent to the 
absorption of (1J) of radiation energy per (kg) of tissue. The relationship between the two 
units is: 
1 rad = 100 erg/g = 0.01 J/kg = 0.01 Gy 
1 Gy = 100 rad 
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Figure 2.6: Absorbed Dose 
 
2.3.5    Dose Equivalent: 
Dose equivalent (H) is the quantity commonly used to express the biological impact of 
radiation on persons receiving occupational or environmental exposures. Personnel 
exposure in a clinical facility is often determined and recorded as a dose equivalent. Dose 
equivalent is proportional to the absorbed dose (D). the quality factor (Q) and other 
modifying factors (N) of the specific type of radiation. Most radiations encountered in 
diagnostic procedures (x-ray, gamma, and beta) have quality and modifying factor values 
of l. Therefore, the dose equivalent is numerically equal to the absorbed dose. Some 
radiation types consisting of large (relative to electrons) particles have quality factor values 
greater than 1 see table 2.2 (Perry Sprawls, 1993). The conventional unit for dose 
equivalent is the rem, and the SI unit is the sievert (Sv). When the quality factor is 1, the 
different relationships between dose equivalent (H) and absorbed dose (D) are: 
H(rem) = D(rad) 
H(Sv) = D(Gy) 
Dose equivalent values can be converted from one system of units to the other by:   
1 Sv = 100 rem. 
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Table 2.2: Radiation Weighting factors. 
Radiation Type and Energy Range Radiation Weighting Factor, WR 
X and γ rays, all energies 1 
Electrons positrons and muons, all energies 1 
Neutrons:  
< 10 keV 5 
10 keV to 100 keV 10 
> 100 keV to 2 MeV 20 
> 2 MeV to 20 MeV 10 
> 20 MeV 5 
Protons, (other than recoil protons) and 
energy > 2 MeV 
2-5 
α particles, fission fragments, heavy nuclei 20 
 
2.3.6    Effective Dose: 
 
Effective dose is becoming a very useful radiation quantity for expressing relative risk to 
humans, both patients and other personnel. It is actually a simple and very logical concept. 
It takes into account the specific organs and areas of the body that are exposed. The point 
is that all parts of the body and organs are not equally sensitive to the possible adverse 
effects of radiation, such as cancer induction and mutations (Perry Sprawls, 1993). For the 
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purpose of determining effective dose, the different areas and organs have been assigned 
tissue weighting factor (WT) values.  
 
If more than one area has been exposed, then the total body effective dose is just the sum 
of the effective doses for each exposed area. It is as simple as that. There is often a need to 
compare the amount of radiation received by patients for different types of x-ray 
procedures (Perry Sprawls, May 1993). 
 
2.3.7    Computed Tomography Dose Index: 
 
The Computed Tomography Dose Index, CTDI, is the special dose quantity that is used 
extensively to express absorbed dose in CT scan. Figure 2.7 shows Computed Tomography 
Dose Index. In CT scan, the x-ray beam is rotated around the patient and passes through 
from all sides. This gives a relatively uniform distribution of absorbed dose within each 
slice. A dose value determined at the center of the slice is usually considered a good 
indicator of tissue dose and can be used to compare imaging techniques and for dose 
management purposes (Perry Sprawls, May 1993).  
One of the complicating factors in determining CT scan dose is that the tissue in a slice is 
exposed to two sources of radiation. One is the direct beam and the other is the scattered 
radiation from adjacent slices in the typical multiple slice imaging procedure. It is the 
contribution from the scattered radiation that is very difficult to measure. Values for the 
CTDI are determined by a measuring protocol that makes a reasonable estimate of the dose 
contribution from scatter.  
A pencil shaped dosimeter (ionization chamber) is placed in a phantom. It is then scanned 
for only one complete slice and the dose value is read. The dosimeter will read the 
radiation from the direct x-ray beam within the slice plus the scattered radiation coming 
out of the sides of the slice and reaching the dosimeter (Perry Sprawls, May 1993). 
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Figure 2.7: Computed Tomography Dose Index. 
 
2.3.8    Computed Tomography Dose Length Product: 
 
The CTDI is the practical quantity for specifying dose in CT scan procedures. The 
associated quantity for specifying the total radiation to a patient is the dose length product 
(DLP). The DLP is just the product of the CTDI value and the length of the body area 
scanned. Figure 2.8 shows Dose Length Product. It has the units of either Gy.cm. It is a 
useful and practical quantity for comparing the total radiation to a patient for various CT 
scan procedures. It is not a precise measure of the total radiation or integral dose that is 
more difficult to determine (Perry Sprawls, May 1993). 
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Figure 2.8: Dose Length Product 
 
2.4  Breast radiation sensitivity: 
 
The Breast tissue of young women is one of the most radiation sensitive tissues in a human 
body. The sensitivity of Breast tissue has been demonstrated in the Japanese atomic bomb 
survivors (Carmichael A.et al, 2003). Also, a significant increased risk in the incident of 
Breast carcinoma has been demonstrated in patients who have received substantial 
cumulative doses to the breast from multiple diagnostic x-ray procedures and from 
radiation therapy for benign diseases (Carmichael A.et al, 2003).  
It has been reported that the delivery of 1 rad to a woman younger than 35 years, can 
increase the lifetime risk of breast cancer by 13.6% (Yilmaz et al, 2007). For comparison, 
breast doses from computed tomography and some nuclear medicine studies are greater 
than 1 rad. The adverse biological effects associated with radiation exposure are classified 
as either stochastic or deterministic and are largely defined by total dose and dose rate. The 
potential radiation effect from doses received in computed tomography is stochastic effects 
due to the magnitude of delivered dose. Stochastic effects are those where the occurrence 
of the effect is dose dependent (Ries LAG et al, 2004).  
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"The International Commission on Radiological Protection (ICRP) Special Task Force 
2000 reported that the doses from computed tomography often approach or exceed levels 
that are known to increase the probability of nonfatal and fatal cancers" (ICRP, 2001). In 
the most recent ICRP publication 103, the breast weighting factor  increased from 0.05 to 
0.12. Table 2.3 shows the reported values in ICRP publication 60 (ICRP, 1990) and (ICRP, 
2007). This is due to recent research showing the increased radiation sensitivity of breast 
tissue and the fact that breast cancer accounts for about one quarter of the total detriments 
in females (Tokunaga M et al, 2007). 
 
Table 2.3: Weighting Factors as defined in ICRP 26,60 and 103. 
Tissue or Organ Weighting factors  
(ICRP 26) 1979 
Tissue Weighting 
Factors (ICRP 60) 
1990 
Tissue Weighting 
Factors (ICRP 103) 
2007 
Bladder - 0.05 0.04 
Bone 0.03 0.01 0.01 
Brain - - 0.01 
Breasts 0.05 0.05 0.12 
Colon - 0.12 0.12 
Esophagus - 0.05 0.04 
Liver - 0.05 0.04 
Lungs 0.12 0.12 0.12 
Ovaries/testes 0.25 0.2 0.08 
Red marrow 0.12 0.12 0.12 
Remainder tissues 0.3 0.05 0.12 
Salivary glands - - 0.01 
Skin - 0.01 0.01 
Stomach - 0.12 0.12 
Thyroid 0.03 0.05 0.04 
Total 1.00 1.00   1.00 
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2.5   Cancer Risk Assessment 
Due to the high doses received through CT scan and the possibility of excessive radiation 
exposure, there Health Physics Society recommends that assessment of radiogenic health 
risks be limited to dose estimate near and above 100 mSv.  Such ranges can patient use 
radiation risk, so as to establish radiation protection measure (Health Physics Society, 
1995). 
The numerical risks derive directly from the organ doses; the female specific risk 
coefficient to give the risk assessment. Table 2.4 shows the terminology that could be used 
to describe risks from radiation exposure (Martine, 2007). Using a variety of mathematical 
models including linear and non-threshold model, cell killing and cell replacement occurs 
through radiogenic effects at any dose, and creating an environment favorable for tumor 
growth, but in high dose the probability is high comparing of low dose, high dose which is 
define more than 100 mSv and low doses less than 100 mSv (Health Physics Society, 
1995). 
Table 2.4: Terminology used to describe risks from radiation exposure (Martin, 
2007). 
Effective dose 
range  (mSv) 
Level of risk Proposed risk Example of medical 
exposure 
<0.1 1 in 1 million Negligible X-ray radiography of  
Chest, limbs, neck and 
teeth 
0.1 – 1 1 in 100,000 Minimum X-ray radiography of 
L.s.spine, Abdomen and 
Pelvis. 
1 – 10 1 in 10,000 Very low Fluoroscopy, CT scan of 
Head, Chest and 
Abdomen and nuclear 
medicines scans. 
10 – 100 1 in 1000 Low Double CT scan for 
contrast enhancement, 
higher dose interventional 
radiology procedure 
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2.6  Literature review 
 
2.6.1  Previous studies: 
 
This section presents other related researchers who conducted studies similar to the 
proponents that will also greatly help in die progress of the study. And it will also help the 
understanding of the proposition. 
A study by (Hurwitz et al, 2006) titled "Radiation Dose to the Female Breast from 16 
Multiple detector computed tomography (MDCT) Body Protocols". The study intended to 
determine the radiation dose to the female breast from current 16-MDCT body 
examinations. Metal oxide semiconductor field effect transistor (MOSFET) detectors were 
placed in four quadrants of the breast of a female configured anthropomorphic phantom to 
determine radiation dose to the breast. Imaging was performed on a 16-MDCT scanner 
using current clinical protocols designed to assess pulmonary embolus (PE) (140 kVp, 380 
mA, and 0.8-sec rotation), appendicitis (140 kVp, 340 mA, and 0.5-sec rotation) and renal 
calculus (140 kVp, 160 mA, and 0.5-sec rotation). Radiation dose to the breast ranged from 
4 to 6 mGy for the PE protocol and up to 1-2 mGy in the inferior aspect of the right breast 
and lateral aspect of the left breast for the appendicitis protocol. The renal calculus 
protocol yielded less than 150 mGy absorbed breast dose. Current clinical chest and 
abdomen protocols result in variable radiation doses to the breast. The magnitude of 
exposure may have implications for imaging strategies. 
 
A study by (Staley, 2012) with the title "Assessing the use of routine abdominal CT in 
staging evaluation of patients with primary breast cancer". The purpose of this study was to 
determine the utility of routine abdominal CT in the staging evaluation of women with 
newly diagnosed primary breast cancer given no detectable disease beyond the ipsilateral 
axillary nodes on chest CT. The chest and abdominal CT scans from 440 patients over a 
10-year period were reviewed. The presence of definite or possible metastatic disease in 
the axillary nodes, chest wall, internal mammary nodes, mediastinal nodes, lungs, liver and 
adrenals were recorded for each patient. Cross tabulation bivariate analysis as well as ache-
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square test was performed to characterize the relationship between detection of disease in 
the chest and disease in the abdomen. Of die 440 patients reviewed, the following were 
found to have detectable metastatic disease by CT scan: axillary nodes 258 of 440 
(56.46%), chest wall 40 of 440 (9.10%), 26 intemalmammary nodes 8 of 440 (1.82%), 
mediastinal nodes 29 of 440 (6.59%), lung 25 of 440 (5.68%), liver 12 of 437 (2.73%), and 
adrenals 8 of 440 (1.82%). In total, 81 patients had disease detectable in the chest beyond 
the ipsilateral axillary nodes, and only 12 patients had detectable disease spread in the 
abdomen. Of the 359 patients who had a negative chest CT, only 1 patient had detectable 
or possible metastatic disease spread on abdominal CT, resulting in a99.70% negative 
predictive value (p < 0.001). The routine use of abdominal CT in women with newly 
diagnosed primary breast cancer and no detectable disease beyond the ipsilateral axillary 
nodes on staging chest CT scan has little value with a 99.70% negative predictive value. 
We recommend that if a negative CT scan of the patient’s chest yields no detectable 
disease beyond the axillary nodes, then further CT imaging of the abdomen is of no 
additional benefit to the patient. 
 
A study by (Lee et al, 2012) by the title "Breast Cancer Risk Estimates Increased with 
Repeated Prior CT ". The purpose of this study is to estimate increased with repeated CT 
imagines. They collected CT dose information from 1,656 patients who Underwent CT 
examinations that exposed the breast to radiation and, using a new automated 
computational method, estimated the patients' effective radiation dose and the amount of 
radiation absorbed by the breast. The researchers then estimated the Women imaging-
related risk of breast cancer and compared it to their underlying risk of developing breast 
cancer. Each woman's 10-year imaging- related risk of Developing breast cancer, 
beginning 10 years after her exposure to imaging and based On her age at exposure, was 
estimated using die breast-specific radiation data and a Statistical risk model. They found 
that young women receiving several chest and or Cardiac CTs had the greatest increased 
risk of developing breast cancer at approximately 20 percent. To lower imaging-related 
risk of developing breast cancer, imaging providers should analyze the radiation doses 
associated with each exam, reduce the use of multi-phase protocols and employ dose-
reduction software Wherever Possible to minimize exposures. 
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A study by (Fuji et al, 2009) studied "Radiation dose evaluation in 64-slice CT 
examinations with adult anthropomorphic phantom". The objective of this study was to 
evaluate the organ dose and effective dose to patients undergoing routine adult CT 
examinations with 64-slice CT scanners and to compare the doses with those from 4-, 8- 
and 16- multislice CT scanners. Patient doses were measured with small (, 7 mm wide) 
silicon photodiode dosimeters (34 in total), which were implanted at various tissue and 
organ 27 positions within adult anthropomorphic phantom. Output signals from photodiode 
dosimeters were read on a personal computer, from which organ and effective doses were 
computed. For the adult phantom, organ doses and effective doses were 8-35 mGy and 7-
18 mSv, respectively, for chest CT. Doses to organs at the boundaries of the scan length 
were higher for 64- slice CT scanners using large beam widths and/or a large pitch because 
of the larger extent of over-ranging. The CT dose index (CTDIvol), dose length product 
(DLP) and the effective dose values using 64-slice CT for the adult phantom was the same 
as those obtained using 4-, 8- and 16-slice CT. Conversion factors of DLP to the effective 
dose by International Commission on Radiological Protection l03 were 0.024 mSv. 
MGy.cm for adult chest CT scans. 
 
A study by (Aldrich JE.et al, 2006) about "Radiation doses to patients receiving computed 
tomography examinations". The purpose of this study was to estimate the diagnostic 
reference levels and effective radiation dose to patients from routine computed tomography 
(CT) examinations. The patient weight, height and computed tomography dose index or 
dose linear product (DLP) were recorded on study sheets for 1070 patients who were 
referred for clinically indicated routine CT examinations at 18 radiology departments in 
British Columbia. Sixteen of the scanners were multidetector row scanners. The average 
patient dose varied from hospital to hospital. The largest range was found for CT of the 
abdomen, for which the dose varied from 3.6 to 26.5 (average 10.1) mSv and for chest CT, 
it was 3.8 to 26 (average 9.3) mSv; Reference dose values were calculated for each exam. 
These DLP values are as follows: chest, 600 mGy cm and abdomen, 920 mGy cm. Among 
hospitals, there was considerable variation in the DLP and patient radiation dose for a 
specific exam. Reference doses and patient doses were higher than those found in similar 
recent surveys carried out in the United Kingdom and the European Union. Patient doses 
were similar to those found in a recent survey in Germany. 
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A study by (Clarke et al, 2000) studied "Application of draft European Commission 
reference levels to a regional CT dose survey". The method used was to study standard 
protocols and calculate doses to the NRPB mathematical phantom, so that a direct 
comparison could be made with other surveys carried out in a similar fashion elsewhere. 
The surrey addressed the patient radiation dose but not image quality or clinical outcomes. 
It is estimated that in Northern Ireland the contribution to collective dose to the population 
28 from CT is about 4% of that from all medical x-rays, the proposed European 
Commission reference quantities, weighted CT dose index and dose- length product were 
computed and their potential use evaluated. A full study of mean values of effective dose 
per examination revealed the average dose per examination was not significantly different 
from that found in the 1989 UK surrey, although several procedures gave rise to doses that 
were high enough to be investigated with a view to justification or reduction. One of the 
scanners was found to give consistently high doses. It is likely that a revision of the mAs 
values used on this scanner will produce a significant reduction in patient doses without 
compromising image quality. When compared with the draft EC reference levels would 
therefore be useful for continual monitoring of CT dose status, but do not appear to provide 
as comprehensive an assessment of patient exposure as that given by consideration of 
effective doses. 
 
A study by (Ngaile et al, 2006) studied Estimation of patient organ dose from CT 
examinations in Tanzania. The aims of this study are, first, to determine the magnitude of 
radiation dose received by selected radiosensitive organ of patients undergoing CT 
examinations and compare them with other studies, and second, to assess how CT scanning 
protocols in practice affect patient organ dose. Patient organ dose from five common CT 
examinations were obtained from eight hospitals in Tanzania. The patient organ doses 
were estimated using measurements of CT dose indexes (CTDI), exposure related 
parameters, and the Impacts spreadsheet based on NRPB conversion factors. The mea 
organ dose in this study for the breast (for chest) was 26.1 mGy. This value was mostly 
comparable to and slightly higher than the values of organ doses reported from the 
literature for the United Kingdom, Japan, Germany, Norway, and the Netherlands. It was 
concluded that patient organ doses could be substantially minimized through careful 
selection of scanning parameters based on clinical indications of study, patient size, and 
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body region being examined. Additional dose reduction to superficial organs would require 
the use of shielding materials. 
A study by (Origgi et al, 2010) by the title of " Survey of computed tomography techniques 
and absorbed dose in Italian hospitals" The aim of this study was the production of the first 
Italian survey of radiation dose in computed tomography (CT) prior to the widespread 
adoption of multislice CT, in order to have a reference point to facilitate later investigation 
of dose exposure changes brought by this new CT modality. The collected dose data were 
compared with diagnostic reference levels (DRLs). The agreement between experimental 
dose evaluation and Monte Carlo (MC) simulations 29 was investigated. The survey was 
carried out in 29 Italian hospitals, covered 48 CT scanners and 232 examinations. The 
dose-length product (DLP) and effective dose (E) values were estimated based on MC 
simulations for seven clinical protocols using the CT-Dose program. Statistical analysis 
showed a significant difference (ᵖ <0.01) in the DLP between the two methods, with MC 
values being greater than the experimental ones. The weighted CT dose index, the DLP 
and E were always below the DRLs set by the European Community. This dose survey 
gives a good but incomplete picture of the Italian CT dose situation and may be useful as a 
reference baseline for defining clinical multislice protocols in the near future. 
 
A study by (Livingstone et al, 2010) studied "Radiation doses during chest examinations 
using dose modulation techniques in multislice CT scanner". The purpose of this study was 
to evaluate the radiation dose and image quality using a manual protocol and dose 
modulation techniques in a 6-slice CT scanner. Two hundred and twenty-one patients who 
underwent contrast-enhanced CT of the chest were included in the study. For the manual 
protocol settings, constant tube potential (kV) and tube current-time product (mAs) of 140 
kV and 120 mAs, respectively, were used. The angular and z-axis dose modulation 
techniques utilized a constant tube potential of 140 kV; mAs values were automatically 
selected by the machine. Effective doses were calculated using dose length product (DLP) 
values and the image quality was assessed using the signal-toniest (SNR) ratio values. 
Mean effective doses using manual protocol for patients of weights 40-60 kg, 61-80 kg, 
and 81 kg and above were 8.58mSv, 8.54 mSv, and 9.07 mSv, respectively. Mean effective 
doses using z-axis dose modulation for patients of weights 40-60 kg, 61-80 kg, and 81 kg 
and above were 4.95 mSv, 6.87 mSv, and 10.24 mSv, respectively. The SNR at the region 
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of the liver for patients of body weight of 40- 60 kg was 5.1 H, 6.2 H, and 8.8 H for 
manual, angular, and z-axis dose modulation, respectively. Dose reduction of up to 15% 
was achieved using angular dose modulation and of up to 42% using z-axis dose 
modulation, with acceptable diagnostic image quality compared to the manual protocol. 
 
A study by (Smith-Bindman et al, 2009) studied "radiation dose associated with common 
CT examinations and the associated lifetime attributable risk of cancer". They sought to 
estimate the radiation dose associated with common CT studies in clinical practice and 
quantify the potential cancer risk associated with these examinations. They conducted a 
retrospective cross sectional study describing radiation dose associated with the 11 most 
common types of diagnostic CT studies performed on 1119 consecutive adult patients at 4 
30 San Francisco Bay Area in situation California. They estimated life time attributable 
risks of cancer by study types from these measured doses. Radiation doses varied 
significantly between the different types of CT studies. The overall median effective doses 
were 31 mSv for a multiphase abdomen and pelvis CT scan. Within each type of CT study 
effective dose varied significantly within across institutions, with a mean 13- fold variation 
between the highest and lowest dose for each study type. The estimated number of CT 
scans that will lead to the development of a cancer varied widely depending on the specific 
type of CT examination and the patient's age and sex. An estimated 1 in 270 women who 
underwent CT coronary angiography at age 40 years will develop cancer from that CT scan 
(1 in 1180 men). For 20 year old patients, the risks were approximately doubled, and for 60 
year old patients, they were approximately 50% lower. Radiation doses from commonly 
performed diagnostic examinations are higher and more variable than generally quoted, 
highlighting the need for greater standardization across institutions. 
 
A study by (Andrew J. Einstein, MD, PhD et al, 2007) studied " Estimating Risk of Cancer 
Associated with Radiation Exposure From 64-Slice Computed Tomography Coronary 
Angiography". Organ doses ranged from 42 to 91 mSv for the lungs and 50 to 80 mSv for 
the female breast. Lifetime cancer risk estimates for standard cardiac scans varied from 1 
in 143 for a 20-year-old woman to 1 in 3261 for an 80-year-old man. Use of simulated 
electrocardiographically controlled tube current modulation (ECTCM) decreased these risk 
estimates to 1 in 219 and 1 in 5017, respectively. Estimated cancer risks using ECTCM for 
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a 60-year-old woman and a 60-year-old man were 1 in 715 and 1 in 1911, respectively. A 
combined scan of the heart and aorta had higher LARs, up to 1 in 114 for a 20-year-old 
woman. The highest organs LARs were for lung cancer and, in younger women, breast 
cancer. 
 
A study by (Rebecca Smith-Bindman, 2009) studied “Radiation Dose Associated With 
Common Computed Tomography Examinations and the Associated Lifetime Attributable 
Risk of Cancer". Radiation doses varied significantly between the different types of CT 
studies. The overall median effective doses ranged from 2 millisieverts (mSv) for a routine 
head CT scan to 31 mSv for a multiphase abdomen and pelvis CT scan. Within each type 
of CT study, effective dose varied significantly within and across institutions, with a mean 
13-fold variation between the highest and lowest dose for each study type. The estimated 
number of CT scans that will lead to the development of a cancer varied widely depending 
on the specific type of CT examination and the patient’s age and sex. An estimated 1 in 
270 women who underwent CT coronary angiography at age 40 years will develop cancer 
from that CT scan (1 in 600 men), compared with an estimated 1 in 8100 women who had 
a routine head CT scan at the same age (1 in 11 080 men). For 20-year-old patients, the 
risks were approximately doubled, and for 60-year-old patients, they were approximately 
50% lower. 
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Chapter Three: 
_____________________________________________________________ 
Materials and Methods: 
 
3.1  Collect, Survey data processing and analysis 
 
This study intended to estimate the breast dose and effective dose from Chest CT scan 
examinations. Data was collected from 10 hospitals in Palestine (West Bank and Gaza 
strip). According to previous experience from literature reviews, effective dose and organ 
dose have been estimated through several steps, and different models used. Data was 
collected from May to November 2016. 
 
3.2  Data collection 
 
Data were collected using a sheet for all patients in order to maintain consistency of the 
information displayed during CT scan examinations (Appendix A).The data used in this 
study were collected from Departments of Radiology in Palestine. Patient data collected 
from these hospitals were further classified into two categories. 
First, data were collected to study the effects of patient related parameters (e.g., age, 
gender, height and weight) (Patient phantom), diagnostic purpose of examination, body 
region and body mass index (BMI) Table 3.1 shows values of patient’s data. A total of 
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approximately 200 female patients under went Chest CT scanning examinations. Doses in 
this study were measured in different CT scan technologies. Table 3.3 shows hospitals and 
different scanners and numbers of slices. The results were tabulated in the tables (mean ± 
standard deviation (SD)) and the range of the readings. The mean and the standard 
deviation were calculated using excel version 2010. 
Secondly, data were collected to investigate the effect of exposure related parameters 
(gantry tilt, peak voltage (kV), tube current (mA), exposure time, slice thickness, table 
increment, number of slices, and start and end positions of scans), and CTDIw and DLP 
Table 3.2 shows exposure parameters data. 
 
Table 3.1: The values of patient’s data during CT scan examinations used each 
hospital in Palestine. 
Hospitals Age  
(years) 
Height 
 (m) 
Weight 
 (kg) 
Body Mass Index 
(BMI)= 
Weight /(Height)
2 
(KG/CM
2
) 
(H1) 49 
(32-66) 
1.69 
(1.6-1.8) 
75.7 
(64-89) 
26.5 
(H2) 40 
(22-66) 
1.66 
(1.6-1.7) 
69.9 
(65-75) 
25.37 
(H3) 50 
(30-75) 
1.67 
(1.55-1.70) 
76.33 
(55-85) 
27.36 
(H4) 42 
(20-68) 
1.73 
(1.6-1.85) 
84 
(60-96) 
28.1 
(H5) 44 
(22-72) 
1.69 
(1.52-1.84) 
72.2 
(52-110) 
25.28 
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Hospitals Age  
(years) 
Height 
 (m) 
Weight 
 (kg) 
Body Mass Index 
(BMI)= 
Weight /(Height)
2 
(KG/CM
2
) 
(H6) 41 
(19-75) 
1.684 
(1.55-1.84) 
73.86 
(65-90) 
26 
(H7) 43 
(24-62) 
1.694 
(1.60-1.80) 
76 
(50-100) 
27 
(H8) 39 
(17-65) 
1.655 
(1.50-1.80) 
81.7 
(60-110) 
30 
(H9) 44 
(19-75) 
1.71 
(1.55-1.80) 
76.93 
(55-90) 
26.6 
(H10) 35 
(18-60) 
1.70 
(1.62-1.80) 
77.73 
(58-95) 
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Table 3.2:  Patient data and exposure parameters of CT scan examinations used each 
hospital. 
Hospitals  Numbers of 
patients 
Exposure setting (mAs) Scan time 
(second) 
(H1) 01 200 4 
(H2) 05 200 4 
(H3) 05 216 6  
(H4) 31 300 20 
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Hospitals  Numbers of 
patients 
Exposure setting (mAs) Scan time 
(second) 
(H5) 30 168 4 
(H6) 21 200 6  
(H7) 01 240 20 
(H8) 01 250 21 
(H9) 01 200 8 
(H10) 01       350 21 
 
3.3    CT scan Machines 
 
Ten CT scan machines were used to collect data during this study. These machines are 
installed in Ten Hospitals radiological departments Table 3.3 shows ten CT scanners in 
Palestine. All quality control tests were performed to the machines prior to any data 
collection. 
Table 3.3: Specifications of CT scanners used each hospital in Palestine. 
Hospital Manufacturer Scanner model/ 
Scan mode 
Field Of View(FOV)/ 
Detector type 
 (H1) Philips Medical 
systems, 
manufactured 
2013. 
Brilliance iCT Big 
Bore, 128 slices, 
Spiral and helical 
modes. 
FAD:60cm 
Detector: Solid State array 
GOS. 
(cadmium tungstate) 
 (H2) Philips Medical 
systems, 
manufactured 
2010. 
Brilliance iCT Big 
Bore, 128 slices, 
Spiral and helical 
modes. 
FAD:60cm 
Detector: Solid State array 
GOS. 
(cadmium tungstate) 
 (H3) Philips Medical 
systems, 
Brilliance iCT Big 
Bore, 128 slices, 
FAD:60cm 
Detector: Solid State array 
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manufactured 
2013. 
Spiral and helical 
modes. 
GOS. 
(cadmium tungstate) 
 (H4) Philips Medical 
systems, 
Manufactured 
2010. 
Multi-slice MX 16 
slices, 
Spiral and helical 
modes. 
FAD:50cm 
Detector: Solid State GOS. 
 
(H5) 
Siemens Medical 
systems, 
Manufactured 
2012. 
SOMATOM 
Definition AS+, 128 
slices, 
Spiral and helical  
FAD:70cm 
Detector: 
Stellar. 
 (H6) Philips Medical 
systems, 
Manufactured 
2012. 
Brilliance 64 
channel with 
essence technology 
Spiral and helical 
Modes. 
FAD:50, 25cm 
Detector: Solid 
State GOS. 
 (H7) 
 
Siemens Medical 
Systems, 
Manufactured 
2010. 
Multi-slice MX 16 
slices, 
Spiral and helical 
modes. 
FAD:≤50cm 
Detector: 
Stellar. 
 (H8) Philips Medical 
Systems, 
Manufactured 
2010. 
Multi-slice 
MX 16 slices, 
Spiral and helical 
Modes. 
FAD:50, 25cm 
Detector: Highlight ceramic 
matrix. 
 
 (H9) Philips Medical 
systems, 
Manufactured 
2011. 
Brilliance iCT Big 
Bore, 128 slices, 
Spiral and helical 
modes. 
FAD:60cm 
Detector:  Highlight ceramic 
matrix 
 
 (H10) Philips Medical 
Systems, 
Manufactured 
2010. 
Multi-slice 
MX 16 slices, 
Spiral and helical 
Modes. 
FAD:50, 25cm 
Detector: Highlight ceramic 
matrix. 
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                          Figure 3.1: Distribution of the CT scan mode in this study. 
3.4   CT Scan dose measurements 
Dose estimation was carried out Monte Carlo method, by inputting patient individual 
exposure parameters of kVp and mAs. Patient's age, height and weight were presented per 
departments. The correlation coefficient which is defined as a measure of the degree of 
linear relationship between two variables, usually labeled X and Y was used in this study 
to describe the relation between effective dose against mAs and DLP. Radiation dose 
indicators CTDIvol and DLP can be obtained from a dose summary page, which includes 
information about the CT scan examination. CTDIvol allows the comparison of scan 
protocols or scanners and is useful for obtaining data to compare techniques, but it is not so 
good for estimating patient dose (Ridely, 2012). DLP is an indicator of the dose imparted 
to the patient is estimated by multiplying CTDIvol times the scan length. In addition to 
being affected by the issues associated with CTDIvol, DLP can be problematic in a limited 
scan range (Ridely, 2012). 
The CTDI is defined as: 
The radiation dose, normalized to beam width, measured from 100 mm length of a pencil 
ionization chamber. 
 
                        CTDI100 = 1/NT  ∫  ( )  
    
     
                   mGy                    3.1 
Where D (z) absorbed dose relative to location along the z axis; N is the number of 
acquired sections per scan (or the number of data channels used during acquisition) and T 
128 slices
64 slices
16 slices
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is the nominal width of each acquired section or slice thickness (product of NT is also 
known as beam collimation). 
The normalized average dose to the slice is: 
                             CTDIw = (1/3 CTDI100, C + 2/3 CTDI100, P)         mGy               3.2 
 
Where CTDI100, C is center location of the phantom, CTDI100, p is average of measurements 
at four different locations around the periphery of the phantom. 
Specific imaging protocols also include the pitch as a factor, thus in Consideration of that 
factor, another descriptor has been created. The unit is CTDIvol or CTDIW. It is defined as: 
                                          CTDIvol = CTDIw. NT/I                          mGy                            3.3 
Where W and T are defined in equation 3.1and 3.2 and represent the total collimated width 
of the X-ray beam and (I) is the table increment per rotation for helical scan or spacing 
between acquisitions for axial scans.                            
Pitch is one of the parameters in spiral CT scan Pitch is defined as table distance travelled 
in one 360° rotation over total collimated width of the x-ray beam, while in conventional 
CT scan it is defined as table increment over slice thickness.  
Pitch can be calculated by the equation 3.3: 
                                                Pitch = I/NT                                                                         3.4 
Thus equation 3.2 can be rewritten as: 
                                                 CTDIvol = CTDIW/Pitch                     mGy                         3.5 
In describing the exposure distribution along the z axis another descriptor known as Dose 
Length Product (DLP) (European Commission 1998) is used as an integral dose quantity. 
This DLP is created as estimated effective dose value without taking account of tissue 
weighting factor.  
The DLP is expressed in units of Gy.cm and given in the equation below: 
                                                 DLP = CTDI vol. Scan length         mGy.cm                       3.6 
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3.5   Breast organ dose estimation 
 
The use of the Monte Carlo method for organ doses estimation in CT scan diagnostics used 
a MIRD V and voxelized patient data. To accomplish this we have modified a general 
purpose Monte Carlo transport code (MCNP4B) to simulate the CT x-ray source and 
movement, and then calculate absorbed radiation dose in desired objects (G Jarry et al, 
2003). The movement of the source in either axial or spiral modes was modeled explicitly 
while the CT system components were modeled using published information about x-ray 
spectra as well as information provided by the manufacturer. Simulations were performed 
for single axial scans using the head and body computed tomography dose index (CTDI) 
polymethylmethacrylate phantoms at both central and peripheral positions for all available 
beam energies and slice thicknesses as seen figure in 3.2 (G Jarry et al, 2003). 
 
 
Figure 3.2:  Phantom models in Monte Carlo Simulation. 
 
This was done by first marking the start and end positions of the scan region and then 
determining the scan length from the number of slices, the slice thickness, and the table 
increment. This information was used in the selection of the part of the phantom irradiated 
in order to improve the correspondence between the organs irradiated in the patient and the 
phantom (IAEA, 2001). 
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The organ equivalent dose (mSv) is given by: 
 
                                               HT = ΣR WR . DT,R                                                                3.7 
 
Where DT, R is the mean absorbed dose to tissue (T) from radiation (R) and WR is the 
radiation weighting factor from the recent ICRP recommendations. Effective dose (E, 
mSv) is a quantity that has been introduced to give an indication of risk from partial or 
non-uniform exposure to risk from an equivalent body exposure. 
E is given by the following equation: 
 
                                                  E = ΣT WT . HT                                                                 3.8 
 
Where HT is the equivalent dose to tissue T and WT is the weighting factor representing the 
relative radiation sensitivity of tissue T. 
 
3.6   Effective dose estimation 
 
CT scanners record the radiation exposure as a DLP in mGy.cm. DLP can be multiplied by 
the appropriate conversion factor to be converted in to effective dose in mSv. The dose 
length is typically saved on picture archiving and communication system (PACS) within a 
radiation report that appears as a separate series in the form of a screenshot as soon in 
Figure 3.2, in the absence of automated or computerized translation of DLP into effective 
dose equivalent, for use of the Monte Carlo method for effective doses estimation in CT 
scan (Ridely, 2012).  
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Figure 3.3: Screenshot shows example of radiation report generated by modern MDCT and 
sent to PACS as separate series, Total dose length product is displayed in mGy.cm and 
CTDIvol is displayed in mGy. 
 
3.7    Monte Carlo Simulation Software 
Virtual Patient incorporation (VPI) is a computer program was founded in 2009 by faculty 
members from Rensselaer Polytechnic Institute (RPI), in collaboration with the University 
of Florida (UF), using the VPI technologies developed from nearly 20 years research at 
RPI and UF in the field of nuclear and radiological engineering. Combining a large 
collection of anatomically accurate models of patients of various ages and sizes and 
sophisticated ―Monte Carlo‖ simulation methods originally developed for nuclear weapons 
research at Los Alamos in the 1940s, VPI is recognized as a world leader in the modeling 
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of ionizing radiation, radiation safety, and medical occupational radiation dosimeter 
(Virtual Phantoms Inc.). 
 
Monte Carlo Simulation CT scan uses cutting edge advances on Monte Carlo simulation 
software to estimate CT doses for the latest CT scanners and International Commission on 
Radiological Protection (ICRP) (Virtual Phantoms Inc., 2016), recommendations across 
multiple anatomically realistic patient phantoms for: 
 Average (or median) adult patients. 
 Children at different ages (newborn, 1, 5, 10, and 15 year old). 
 A pregnant female at three gestational stages (3, 6, and 9 month). 
 Overweight and obese patients. 
 
The entrance surface dose by direct measurements on patients using TLDs could accurately 
estimate the dose to this superficial organ not internal organ. There are we used Monte 
Carlo Simulation to accurately estimate internal Organ dose and Effective dose. Virtual 
Dose CT scan is sophisticated radiation dose simulation software for radiologists, 
technologists, and medical physicists. See Figure 3.3 which shows Monte Carlo modeling 
Simulation radiological software.  
Virtual Dose CT scan enables users to assess organ doses, in addition to CTDI and DLP 
data provided by the CT scanner.  It is able to differentiate for individuals outside of the 
―average‖ population body habitus. It is ready for use with the latest CT scanners and with 
recent ICRP-60 and ICRP-103 recommendations on effective dose. 
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Figure 3.4: Monte Carlo Simulation software. 
 
3.8   Breast cancer risk assessment  
 
The risk (RT) of developing cancer in a particular organ (T) following after irradiation was 
estimated by multiplying the mean organ equivalent (HT) dose with the risk coefficients 
(FT) obtained from ICRP. 
 
                                               RT = HT . FT                                                                       3.9 
 
The overall lifetime mortality risk (R) per procedure resulting from cancer / heritable was 
determined by multiplying the effective dose (E) by the risk factor (F). The risk of genetic 
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effects in future generations was obtained by multiplying the mean dose to the ovaries by 
the risk factor (ICRP, 1991). 
 
                                               R = E.F = ΣRT                                                                 3.10 
 
3.9   BEIR VII Risk Modeling 
 
The Seventy Biological effects of Ionizing Radiation Committee Phase Two (BEIR VII 
Phase 2) committee was convened in 1998, after a Phase 1 committee formed to address 
the US Environmental Protection Agency’s request of the National Academy of Sciences 
to evaluate the need for a follow up of health effects of low levels of ionizing radiation had 
concluded that such follow up was necessary.  
The 17 member of BEIR VII Phase 2 were composed of international experts in a variety 
of scientist fields to develop theory and models found solve this problem about "Develop 
the best possible risk estimates for exposure to low dose, low linear energy transfer 
radiation in human subjects" (Andrew J. Einstein et al, 2007). 
For each age, sex and organ, the estimated lifetime attributable risk (LAR) of cancer 
incidence from 100 mSv organ equivalent dose was determined using Table 12D-1 see 
Table 3.4 of the BEIR VII report. If data were not available for a specific age, then linear 
interpolation was performed from the 2 nearest tabulated ages.  
This LAR from a theoretical 100 mSv organ dose was scaled linearly based on the actual 
organ dose determined in the Monte Carlo simulation. For example, the breast equivalent 
dose for a 50 year old woman from a standard Chest CT scan is 12 mSv; the LAR of 
Breast cancer incidence for a 50 year old woman from a 100 mSv Breast dose is 70 cases 
per 100 000 by the BEIR VII preferred model, so the LAR from a 12 mSv dose is (12/100) 
x (70/ 100, 000) or 0.008% or 100,000 / (12/100) x 70 = 1 in 6803 (BEIR VII Phase 2, 
2006). 
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Table 3.4: Table 12D-1 lifetime attributable breast cancer risk of incidence (BEIR 
VII Phase 2, 2006). 
Age at 
Exposure 
(years) 
Females 
 
 
0 
 
 
5 
 
 
10 
 
 
15 
 
 
20 
 
 
30 
 
 
40 
 
 
50 
 
 
60 
 
 
70 
 
 
80 
Stomach 101 85 72 61 52 36 35 32 27 19 11 
Colon 220 187 158 134 114 82 79 73 62 45 23 
Liver 28 23 20 16 14 10 10 9 7 5 2 
Lung 733 608 504 417 346 242 240 230 201 147 77 
Breast 1171 914 712 553 429 253 141 70 31 12 4 
Uterus 50 42 36 30 26 18 16 13 9 5 2 
Ovary 104 87 73 60 50 34 31 25 18 11 5 
Bladder 212 180 152 129 109 79 78 74 64 47 24 
Other 1339 719 523 409 323 207 181 148 109 68 30 
Thyroid 634 419 275 178 113 41 14 4 1 0.3 0.0 
All solid 4592 3265 2525 1988 1575 1002 824 678 529 358 177 
Leukemia 185 112 86 76 71 63 62 62 57 51 37 
All cancers 4777 3377 2611 2064 1646 1065 886 740 586 409 214 
 
NOTE: Number of cases per 100,000 persons exposed to a single dose of 0.1 Gy. 
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Chapter Four: 
_____________________________________________________________ 
Results and discussion: 
 
4.1    Chest CT scans parameters and absorption dose  
 
A total of 200 female patients underwent Chest CT examinations in Palestine. Appendix C 
and Table 4.1 shows DLP and CTDIvol for patients in ten hospitals in Palestine. There are 
wide variations in patient’s doses among different CT scanner, parameters such as ordinary 
CT scan DLP and CTDIvol. The values of DLP range (410 - 1067) mGy.cm and CTDIvol 
range (3.75 – 16.6) mGy for Chest CT scan in Palestine. 
The kVp was the same (120 kVp) for all hospitals; the trend was almost the opposite for 
mAs product, which a large variation ranging from 168 to 350 mAs for Chest CT scan for 
different hospitals, and these variation caused for different in CT scanner and focus to 
isocenter distance among scanners (Radio protective garments, 2013).  
The radiation intensity is inversely proportional to the square of the distance between the 
focus and the patient, this intensity due to shorter distance, and lower the mAs values, 
while the longer the distance due to higher the mAs values. The scan length (calculated 
from slice thickness, table increment, and number of slices) varied among scanners (Radio 
protective garments, 2013). 
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Table 4.1: means of CTDIvol, DLP and Pitch for patient during Chest CT scan used 
each hospital. 
Hospitals CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x Pitch 
 
Pitch DLP   
(mGy.cm) 
(H1)  6 6 1 423 
(H2)  8 8 1 410 
(H3)  7.7 7.7 1 410 
(H4)  11 10 0.9 978 
(H5)  5.6 5 0.9 427 
(H6)  6 6 1 406 
(H7)  8 7 0.9 967 
(H8)  15 13.5 0.9 0111 
(H9)  3.75 3.75 1 407 
(H10)  16.6 14.8 0.9 1067 
 
CT examination, patients are exposed to high radiation dose for use of ordinary dose 
values (CTDIvol and DLP). Comparisons between different parameters are possible with 
different imaging modalities (Radio protective garments, 2013). Table 4.2 shows the 
effective doses and breast doses for female underwent Chest CT examinations for range (3 
– 14.7) mSv, (6.5 – 28) mGy, respectively, the effective dose variation related to the 
manufacture model related to number of slices used. The breast organ dose variation 
related to spot focusing about the CTDIvol parameters factor (Radio protective garments, 
2013). 
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Table 4.2: shows means Effective doses and breast doses for female Chest CT scan. 
 
Hospitals Effective dose  (mSv) Breast Dose (mGy) 
(H1) 6.5 13.6 
(H2) 7 13 
(H3) 8 14 
(H4) 8.8 22 
(H5) 4.6 8.6 
(H6) 5.4 12.4 
(H7) 6.5 15 
(H8) 14.7 28 
(H9) 3 6.5 
(H10) 8.5 17.5 
 
Table 4.2 shows values of effective and breast doses in ten hospitals in Palestine, the H9, 
H5, H1, H2 and H3 are low values of effective and breast doses because they are used the 
same CT scanner manufacture model is 128 slices, the H6 CT scanner is 64 slices, and the 
H8, H10, H4 and H7 are high values of effective and breast doses because they are used 
the same CT scanner manufacture model is 16 slices.  
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4.2    CTDIvol for female Chest CT scans in different hospitals in Palestine 
 
The breast and effective doses cannot be determined without the knowledge of CTDIvol 
parameter; the values of CTDIvol for female patients underwent Chest CT scans in ten 
hospitals in Palestine are presented in Figures 4.1. 
 
Figure 4.1: CTDIvol in different hospitals in Palestine. 
 
Figure 4.1 shows CTDIvol in different hospitals for female Chest CT scans in Palestine. 
Have a variation in CTDIvol because there are a different in scanner manufacture models 
and software version (Hurwitz et al, 2006). 
The amount of radiation in CT examinations is based on a unique dose metric CTDIvol, the 
CTDIvol is obtained by using a 100-mm-long pencil-shaped ionization chamber in one of 
two phantom sizes (16 or 32 cm in diameter). Most manufacturers use a 32-cm phantom to 
calculate CTDIvol for chest CT examinations (Huda W et al, 2010). 
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The relatively high values shows for H10, H8, H4 and H7 are used manufacture scanner is 
16 slices and probably a function of their short focus to axial distance, the scanner with the 
shorter distance between the x-ray tube focal spot and the isocenter of the gantry aperture 
can produce more radiation exposure than the long geometry scanner.  
On the other hand, the variation of source to detector distance among scanners affects the 
image quality (Hurwitz et al, 2006), and due to image noise in Chest CT scan, inversely 
proportional to the square root of the number of photons received by the detector, whereas 
the number of photons (dose) is inversely proportional to the squared distance between the 
source of the radiation and the detector (Hurwitz et al, 2006).   
As a result, if all other scanning parameters are held constant. The difference in the case of 
H10 and H9 is probably the result of the use of different CT scanners and used different 
parameters such as CTDIvol, by use different slice thickness and pitch, whereas using thin 
slices to the same scan length, pitch will increase to have decrease CTDIvol. Figure 4.1 is 
evident the effect of slice thickness on CTDIvol (Hurwitz et al, 2006). 
 
4.3  DLP for female Chest CT scans in different hospitals in Palestine 
 
Another important parameter is DLP to determine effective and breast doses for female 
Chest CT scans in ten hospitals in Palestine are presented in Figure 4.2. 
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Figure 4.2: DLP values in ten hospitals in Palestine. 
 
Figure 4.2 shows DLP in different hospitals for female Chest CT scans in Palestine. Have a 
variation in DLP because there are a different in scanner manufacture models and software 
version for used different mAs and kVp parameters (Hurwitz et al, 2006). 
DLP is the total amount of radiation incident on the patient, product of the CTDIvol and 
scan length cm and is measured in mGy.cm. The DLP is the second dose metric that is 
accounts for both radiation intensity (CTDIvol) and scan length in the CT examination. 
Indicate the total amount of radiation (intensity × scan length) used to perform the CT 
examination and are quantified in a cylindrical phantom of a specified size 16 or 32 cm in 
diameter (Huda W et al, 2010). 
The values of DLP relatively high values in H10, H4, H7 and H8 for his values is 1067, 
987, 967 and 963 mGy.cm, respectively, to compare with low values in H9, H6, and H3 for 
his values is 407, 406 and 410 mGy.cm, respectively. With different manufacture models 
and number of slices, correctly, with the length of the irradiated body section, there is most 
likely variation values of the CTDIvol and variation scan length for z-axis. (Hurwitz et al, 
2006).  
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In most cases this procedure involves a repeated scan of the same scan length. Variations 
as also observed elsewhere were largely caused by different scanning parameters such as 
slice thickness, number of slices, mAs, kVp and pitch) and larger scanning regions 
(Shrimpton PC, et al, 1991). 
 
4.4   Relationship between BMI and Effective dose for female Chest CT 
scan in different hospitals in Palestine 
 
Patients’ biological features are considered of an important exposure technical determinant 
factors. The BMI is an attempt to quantify the amount of tissue mass (muscle, fat, and 
bone) in an individual, and then categorize that person as underweight, normal 
weight, overweight, or obese based on that value.  The body mass index (BMI) patients are 
exposed highly. 
   
Figure 4.3: correlation between BMI and Effective dose for female  patient 
underwent Chest CT examination in ten hospitals in Palestine. 
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Figure 4.3 shows the correlation between the effective dose and the BMI for female 
underwent CT scan, the squared correlation coefficient (r
2
) = 0.709, which show a linear 
relationship between ten hospitals in Palestine. The BMI (kg.cm
2
) was obtained for each 
patient to analyze effective dose variations relative to body size, the goal of using height 
and weight was to obtain an estimate of the effect of patient dimensions on effective dose 
from Chest CT scan protocols. To estimate the effective dose for the CT scans whole body 
(Chest). The coefficient of determination, R
2
, was used to describe the variability in the 
calculated effective dose explained by the linear regression (DHHS, 2006). 
Strong positive relationship between BMI and effective dose for different hospitals in 
Palestine, to increase BMI is increase effective dose.  
Relationship between BMI and Effective dose important to describe and determinate the 
effective dose in human body (Smith Bindman, 2009). BMI points are different values of 
effective dose depending of on the CT scan manufacturer model such as 16, 64 and 128 
slices and put parameters without considering patient weight (Rebecca Smith-Bindman et 
al, 2011) 
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4.5  Relationship between CTDIvol and Effective dose for female Chest 
CT scans in different hospitals in Palestine 
The volume CTDI (CTDIvol), defined as CTDIw divided by the beam pitch factor.  
     Figure 4.4: correlation between CTDIvol (mGy) and Effective dose (mSv) for 
female patient underwent Chest CT scan in all hospitals. 
 
Figure 4.4 shows the correlation between CTDIvol (mGy) and effective doses (mSv), the 
squared correlation coefficient (r
2
) = 0.88, which show that strong positive correlation, 
variability in patient's effective doses can be related to mAs and the effective dose as a 
functional of CTDIvol for difference CT scanners. The CTDIvol of CT scans most important 
parameter to optimize different hospitals in Palestine. 
High values of CTDIvol gave high values of effective dose, any change of CTDIvol value 
leads to a change in effective dose value which means that the relation is ascending. 
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Variations in CTDI with identical radiographic techniques (such as kilovolt peak and 
milliampere second) result from differences in CT scan tube design, tube filtration, and 
beam shaping (bow tie) filters. 
CT scan and acquisition parameters such as CTDIvol are ―fixed‖ and independent of patient 
size and scan length. The CTDIvol does not quantify how much radiation any specific 
patient receives, but indicates the intensity of the radiation being directed at that patient. 
When the same amount of radiation is directed to a young female and an oversized adult, 
the resultant breast dose and effective dose are substantially higher in the younger female 
than in the older female. At constant techniques, doses are lower in large patients, because 
the CT scan beam is attenuated to a greater extent in large patients than in small patients 
(Walter Huda, 2011). 
 
4.6  Effective dose for female Chest CT scan in different hospitals in 
Palestine 
 
Effective dose estimated by Monte Carlo Simulation for female Chest CT examinations in 
different hospitals in Palestine. Figure 4.5 mean effective dose for female Chest CT 
examination in different hospitals in Palestine. 
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Figure 4.5: mean value of effective dose for female Chest CT scan in different 
hospitals in Palestine. 
 
The variation of effective doses in Figure 4.5 is about 3 - 14.7 mSv the H8, H4 and H10 
high values effective doses 14.7, 8.8 and 85 mSv, respectively, and low values in H9, H5 
and H6, there are 3, 4.6 and 5.4 mSv, respectively, for all Chest CT scans which is an 
indication that different scanner manufacture models such as single slice 16 slices and 
multi slice 64 and 128 slices and parameters such as mAs, scan length, and Pitch, hospitals 
have a significant influence on breast dose determination (Hurwitz et al, 2006).  
The effective doses from diagnostic CT examination are typically estimated to be in the 
range of 1 to 10 mSv. This range is not much less than the lowest doses of 5 to 20 mSv 
received by some of the Japanese survivors of the atomic bombs. These survivors, who are 
estimated to have experienced doses only slightly larger than those encountered in CT 
scan, have demonstrated a small but increased radiation related excess relative risk for 
cancer mortality (BEIR VII Phase 2). 
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In Palestine the range is 3 to 14.7 mSv, this range is suitable with BEIR VII Phase 2, 
except H8 used high parameters such as mAs and kVp, so the effective dose is high, high 
than the highest of value for BEIR VII Phase 2. 
 
4.7  Breast dose for female Chest CT scan in different hospitals in 
Palestine 
Breast dose estimated by Monte Carlo Simulation for female Chest CT examinations in 
different hospitals in Palestine. Figure 4.6 shows mean breast dose in different hospitals in 
Palestine.   
 
 
Figure 4.6: mean values of breast dose for female CT scan in different hospitals in 
Palestine. 
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Figure 4.6 shows observed wide variation of breast doses is about (6.5 - 28) mGy, the H8, 
H4, H10 and H7 high values breast doses 28, 22, 17.5 and 15 mGy, respectively, and low 
values in H1, H2, H3, H5, H6 and H9, there are 13.65, 13, 14, 8.5, 12.4 and 6.5 mGy, 
respectively, for Chest CT scan in Palestine which is an indication that different 
manufacture scanners such as single slice 16 slices and multi slice 64 and 128 slices and 
different parameters such as mAs, scan length, CTDIvol, DLP and pitch in different 
Palestine hospitals have had a significant influence on breast doses (Hurwitz et al, 2006).  
CT examination performed for Chest, a quantifiable dose is received by the female breast 
tissue when positioned in the scanning region. Therefore, the breast dose is higher for 
Chest CT scan studies as compared to abdomen studies, the probability of cancer due to 
radiation dose depends on organ dose, age and tissue weighting factor (Hurwitz et al, 
2006). 
The quantity most relevant for assessing the risk of cancer detriment from a Chest CT 
examination is the breast dose.  Breast dose allows for comparison of the risk estimates 
associated with breast soft tissue. It also incorporates the radiation sensitivities of the 
breast in the body. Radiation dose from CT examination varies from patient to patient. The 
particular radiation dose will depend on the breast size of the Chest CT scan examined, and 
the type of CT scan and its operation (U.S. Food and Drug Administration). 
 
4.8    Effective and breast doses for female Chest CT scan in Palestine 
 
Radiation dose from CT scan is a subject of concern to radiologists, radiographers, 
physicians, scientists and patients. Organizations such as the International Atomic Energy 
Agency (IAEA), the European Society of Radiology (ESR), the U.S. Food and Drug 
Administration, and the Joint Commission have recommended mean dose for patients not 
only for estimating potential risk of radiation exposure but also for protocol optimization, 
standardization, and quality assurance (Natalia Saltybaeva, 2014). It can be used for 
comparison and mean of dose for different modalities, which is why it is used for this 
purpose (Natalia Saltybaeva, 2014). Table 4.3 shows means Effective and breast doses in 
Palestine. 
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Table 4.3:    means effective and breast doses in Palestine. 
 
 
 
In Palestine 
Effective dose  
(mSv) 
Breast organ dose 
 (mGy) 
 
7 
 
15 
 
The effective and breast doses in Palestine had have not exceed the international 
commission such as ICRP and others internationals such as U.K and Germany, and this 
situation perfect because the Palestinian population patients underwent Chest CT scan 
should not dangerous for diagnosis and treatment in Palestine hospitals.   
 
4.9   CT scan radiation doses between Palestine and other internationals 
 
4.9.1  Comparison between CTDIvol, DLP and Effective Dose for female 
Chest CT scan in Palestine and other countries:  
 
The measurement CTDIvol, DLP and effective doses from CT examinations are comparable 
to others countries.  
Figure 4.7 shows CTDIvol from CT examination in Palestine and other countries. 
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Figure 4.7: comparison between CTDIvol in Palestine and other countries for female  
Chest CT scan. 
 
Figure 4.7 shows the mean values of CTDIvol in Palestine is about 8.76 mGy and this value 
low with others countries such as Germany, Italy, Taiwan, France, Poland and Greece, and 
high value to comparison with United Kingdom could be due to broad range of mAs and 
pitch employed (ICRP Publication 60, 1991). 
 
Figure 4.8 shows DLP from CT examination in Palestine and other countries. 
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Figure 4.8: comparison between DLP in Palestine and other countries for female 
Chest CT scan. 
 
Figure 4.8 shows DLP (mGy.cm) from CT examination in Palestine and other countries, 
the mean values of DLP in Palestine is about 645.8 mGy.cm and this value comparable 
with France and high with United Kingdom, Taiwan and Poland, Germany, and Greece. 
This variation related to use manufacture scanners and mAs and scan length values (ICRP 
Publication 60, 1991). 
 
Figure 4.9 shows Effective dose from Chest CT examination in Palestine and comparison 
other countries. 
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Figure 4.9: comparison between Effective doses in Palestine and other countries for 
female Chest CT examination. 
 
Figure 4.9 shows effective dose CT examination in Palestine and others countries, the 
mean value of effective doses in Palestine is about 7 mSv, the Palestine is the highest 
values to compare with Germany, United Kingdom and France and lower than Italy, 
Taiwan, Poland and Greece. Reduction effective dose from CT examination can be 
achieved by reducing the mAs and pitch of the examination protocol, but this requires a 
careful consideration of the signal to noise in order to avoid significant degradation of 
image quality and the resulting examination repeats.  
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4.9.2  Comparison between breast doses for female Chest CT scan in 
Palestine and Reference values of the International commission on 
radiological  protection 60 (ICRP 60) 
 
Table 4.4: comparison between breast dose in Palestine and Reference value of the 
International commission on radiological protection 60 (ICRP 60). 
Comparison between 
Palestine and ICRP 
Breast doses     
(mGy) 
Reference value of the 
(ICRP) 
(mGy) 
Breast dose from 
Chest CT scan  
mGy 
 
15 
Not exceed 
 
45 
 
Table 4.4 shows estimated effective doses from Chest CT examination are comparable 
than the doses from those others countries. The variation in these doses may be due to 
differences in manufacture CT scanner and exposure parameters. Female Chest CT 
examinations appear a low breast dose, ranging from 6.5 to 28 mGy. Table 4.4 shows 
estimated breast dose from CT examinations in Palestine and comparison with 
International commission on radiological protection (ICRP) breast dose should not exceed 
45 mGy (ICRP Publication 60, 1991). Palestine Compared with the ICRP 60 is not should 
exceed 45 mGy, Therefore, The reason is adopt an effective strategy for the prevention of 
radiation in hospitals in Palestine (ICRP Publication 60, 1991). 
 
 
 
 
 
64 
 
4.9.3  Breast dose for female Chest CT scan in Palestine and other 
Internationals 
Table 4.5: breast doses for female Chest CT scan in Palestine and comparison with 
others countries. 
 
Comparison between 
Palestine and other 
Internationals 
 
Palestine 
 
 
United 
Kingdom 
 
Germany 
 
Netherlands 
 
Japan 
Breast doses from Chest CT 
scan  
mGy 
 
15 
 
21 
 
22 
 
32 
 
16 
 
 
Assess radiation dose to selected radiosensitive breast organs of female patients underwent 
in Chest CT examinations in Palestine was investigated. Variations of radiation dose to 
breast observed in Table 4.5. Different scanning parameters are use among hospitals and 
variation in scanner design among manufacturer models was responsible for these 
variations (Hidajat N et al, 1999). 
The breast doses in Palestine to comparison with United Kingdom, Germany, Netherlands 
and Japan has been presented in Table 4.5 (Hidajat N et al, 1999). Conversion factors were 
mainly attributed to the variation in CT manufacture scanner and parameters such as, kVp, 
mAs, slice thickness, number of slices, pitch, etc. and types of scanners used. (Hidajat N et 
al, 1999). 
 
 
 
 
65 
 
4.10   Risk Assessment Calculations 
 
4.10.1   Lifetime attributable breast cancer risk for female Chest CT scan 
in different hospitals in Palestine: 
 
Calculated breast absorbed doses can be used for risk assess of medical radiation exposure 
which can induce cancer. The Committee on the Biological Effects of Ionizing Radiations 
Phase 2 modeling (BEIR VII Phase 2) estimates the risk factors (BEIR VII Phase 2, 2006).  
The BEIR VII has been derived by lifetime risk estimates for cancer incidence and 
mortality resulting from a single dose of 0.1 Gy at several specific ages. Estimates are 
shown for all cancer, leukemia, Breast, all solid cancer and cancer of several specific sites 
(BEIR VII Phase 2, 2006), Average age dependent mortality are used for subsequent 
assessment of lifetime cancer risk (BEIR VII Phase 2, 2006). 
The estimate the lifetime risk of cancer resulting from any specified dose of ionizing 
radiation and applies, such as CT scan, these models to example exposure scenarios for the 
U.S. population. Models are developed for estimating lifetime risks of cancer incidence 
and mortality and take account of gender, age at exposure, dose rate, and other factors. 
Estimates are given for all solid cancers, leukemia, breast, and cancers of several specific 
sites. Like previous BEIR reports addressing low LET (linear energy transfer) radiation.  
"The risk models are based primarily from data on Japanese atomic bomb survivors. 
However, the vast literature on both medically exposed persons and nuclear workers 
exposed at relatively low doses has been reviewed to evaluate whether findings from these 
studies are compatible with A bomb survivor based models" (BEIR VII Phase 2, 2006). 
Risk estimates are subject to several sources of uncertainty due to inherent limitations in 
epidemiologic data and in our understanding of exactly how radiation exposure increases 
the risk of cancer. The populations and exposures for which risk estimates are needed 
nearly always differ from those for whom epidemiologic data are available (BEIR VII 
Phase 2, 2006). 
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Appendix D and Figures 4.10, 11, 12, 13, 14, 15, 16, 17, 18 and 19 summarize the risk 
assessment of different hospitals in Palestine, which depends on the organs equivalent 
absorbed doses were estimated in this study.   
4.10.1.1 Age, Female Gender and Cancer Risk 
Estimated risk of cancer incidence attributable for female patients underwent in chest CT 
scan are shows in appendix D and Figure 4.10, 11, 12, 13, 14, 15, 16, 17, 18 and 19. The 
Lifetime attributable cancer risk (LAR) for different female patients age, the breast risks 
were high for female in their young female and decreased to old female markedly as a 
function of age (Andrew J. Einstein et al, 2007).  
Radiosensitivity such as breast has been observed to decrease with age (Andrew J. Einstein 
et al, 2007). To irradiate along time in CT scan procedure will be development to 
malignant breast cancer, young female for minimum reaction time from radiation exposure 
to excess breast cancer risk have been described in Japanese atomic bomb survivors (Land 
CE, 2003).  
The older female patients underwent chest CT scan in Palestine, who were both less 
radiosensitivity and less likely to development of a radiation attributable breast risk cancer, 
Figure 4.10, 11, 12, 13, 14, 15, 16, 17, 18 and 19 shows lifetime attributable breast cancer 
risk in ten hospitals in Palestine. 
 
The Lifetime attributable breast cancer risk (LAR) is: 
 
LAR =  
                 
      
  x  
                   
       
 .   % 
Or 
 
         LAR =   1   in          
 
                 
      
                         ⁄
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Figure 4.10: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital one in Palestine 
 
Figure 4.11: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital two in Palestine 
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Figure 4.12: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital three in Palestine 
 
Figure 4.13: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital four in Palestine 
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 Figure 4.14: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital five in Palestine 
 
Figure 4.15: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital six in Palestine 
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Figure 4.16: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital seven in Palestine 
 
Figure 4.17: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital eight in Palestine 
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Figure 4.18: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital nine in Palestine 
 
Figure 4.19: Shows Lifetime Attributable Risk of breast Cancer Incidence from 
female Chest CT scan in hospital ten in Palestine 
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Figure 4.20: Shows lifetime attributable breast risk of cancer incidence for female 
chest CT scan in Palestine. 
 
Our basic technique is to multiply age dependent lifetime breast cancer incidence risks (per 
unit dose) by estimated age dependent doses produced by various CT examinations. The 
age dependence of the cancer incidence risk varies considerably from site to site Figure 
4.10, 11, 12, 13, 14, 15, 16, 17, 18 and 19 for a highly inhomogeneous dose distribution, as 
produced by a CT examination; the age dependence of the overall cancer risk cannot be 
directly estimates of the total cancer incidence per unit effective dose. Rather, the age 
dependence of the risks for the various groups of sites shown in Figure 4.20 are each 
separately calculated by applying appropriate site specific doses to the age and site per 
breast dependent risks in Figure 4.20 and these site specific risks are then summed to yield 
the overall age dependent lifetime cancer incidence risk. 
 
0
0.0001
0.0002
0.0003
0.0004
0.0005
0.0006
0.0007
0.0008
0.0009
0 20 40 60 80
Li
fe
ti
m
e 
 a
tt
ri
b
u
ta
b
le
   
b
re
as
t 
  c
an
ce
r 
  r
is
k 
 %
 
Age   Y 
73 
 
4.10.2  Effective and breast doses and lifetime attributable breast cancer 
risks in Palestine: 
 
To estimate radiation related breast cancer risks, converted each patient’s CT scan organ 
equivalent dose to estimate lifetime attributable breast cancer risk used the standardized 
BEIR VII.  
 
Table 4.6: shows means effective dose, breast dose and lifetime attributable breast 
cancer risks for younger and older female patient’s ages in Palestine. 
 
 
 
 
In 
Palestine 
 
Effective dose 
 (mSv) 
 
 
 
Breast dose 
 (mGy) 
 
 
 
Lifetime attributable breast cancer risk  
(%) 
 
 
 
 
7 
 
 
15 
Young Female 
(15 – 39) 
Old Female 
(40 – 60) 
 
0.00042 % 
 
1 in 2645 
 
 
 
0.00014 % 
 
1 in 10,473 
 
 
The risk versus benefit for female patients may justify the potential risks of no imaging or 
of imaging with a potentially less accurate technique that delivers less of ionizing radiation 
as soon as possible (Richard T. Griffey and Aaron Sodickson, 2009). And they are 
important to applicable for every female patient underwent Chest CT scan examination to 
make best diagnostic.  
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4.10.3   Breast cancer risk assessment for female underwent Chest CT 
scans in different ages in Palestine  
 
Table 4.7: Shows Mean lifetime attributable breast cancer risk for female patients 
ages (15 – 29, 30 – 39, 40 – 49, 50 – 59, 60 – 69 and 70 - 79) years for Chest CT scan in 
Palestine. 
Age 
Years 
 
lifetime attributable breast cancer risk for female in Palestine 
% 
 
15 - 29 
 
0.00054 %  
1 in 2340 
 
30 - 39 
 
0.0003 % 
1 in 2949 
 
40 - 49 
 
0.00019 % 
1 in 6534 
 
50 - 59 
 
0.00009 % 
1 in 14,412 
 
60 - 69 
 
0.00004 % 
1 in 29,159 
 
70 – 79 
 
0.00001 % 
1 in 89,415 
 
Table 4.7 shows breast cancer risk for younger and older female for Chest CT scan in ten 
hospitals in Palestine. CT scan parameters factors and breast sensitivity affect the breast 
cancer in younger female than older female (Tokunaga M et al, 2007).  
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Doses from CT scan in the Chest protocol are shows in Table 4.6. Estimated lifetime 
attributable breast cancer risk to a single and multi CT scan are shows in Figure 4.20. The 
LAR for a 15 – 39 years young female was 0.00042 % or 1 in 2645. Risks were 
particularly high for female in their 15 – 39 years and decreased markedly as a function of 
age. For a 40 – 60 years old female, the LAR was 0.00014 % or 1 in 10,473, and for 70 – 
80 years female, the LAR was 0.00001 % or 1 in 89,415.  
The lifetime attributable breast cancer risk markedly variable by hospitals and used 
parameters. The risks reduced with age, so radiation associated cancer risks are particular 
concern for younger female patients, because the risks of cancer are high among younger 
patient. Although it is generally assumed that very little CT examination occurs in children 
and young female. 
Age Dependent Doses from CT Examinations 
various calculations and measurements are available of the doses produced by a variety of 
CT examinations under different conditions, the most comprehensive being the results of a 
1989 survey of CT practice in Britain, in which organ doses were estimated for 17 CT 
examinations from more than 100 CT scanners (Shrimpton PC et al, 1991). 
Estimated lifetime breast cancer incidence risks from chest CT examinations are somewhat 
greater for younger women than older women, an effect that is caused by the significantly 
greater estimated risks per unit dose Table 4.7. The estimated risk for chest CT 
examinations decreases much more slowly with increasing age at examination. 
The doses and risks estimated depend roughly linearly on the exposure settings assumed. 
The survey data from which the doses were estimated yielded average exposure settings of 
168 - 350 mAs and DLP from 410 - 1067 mGy.cm for Chest CT scans. 
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4.10.4  Breast cancer risk assessment for female underwent Chest CT 
scans in Palestine and comparison with ICRP Recommendations: 
Table 4.8: Shows means lifetime attributable breast cancer risk for younger and older 
female patients underwent Chest CT scan in Palestine and comparison with ICRP 
Recommendations (ICRP, 2011). 
 
Age 
Years 
 
lifetime attributable breast 
cancer risk for female in 
Palestine 
% 
 
lifetime attributable breast 
cancer risk  
 % 
ICRP, 2011 
 
Young Female 
 
15 - 39 
 
0.00042 % 
 
1 in 2645 
 
 
 
0.00865 % 
 
 
Old Female 
 
40 - 60 
 
0.00014 % 
 
1 in 10,473 
 
 
0.00160 % 
 
Table 4.8 shows lifetime attributable breast cancer risk for younger and older female 
patients underwent Chest CT scan in ten hospitals in Palestine and comparison with ICRP 
Recommendations in 2011. The lifetime attributable breast cancer for Chest CT scan in 
Palestine not a fatal cancer at all ages, because the fatal breast cancer according to ICRP is 
about 1.3 – 2.6 % at same age in the table 4.8 (ICRP, 2007). 
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4.10.5  Breast Cancer Risk assessment for female underwent Chest CT 
scans in different hospitals in Palestine 
Lifetime attributable breast cancer risk for female patients ages (15 – 70) years for Chest 
CT scan in different hospitals in Palestine. 
   
 
Figure 4.21:  Lifetime Attributable breast cancer risk incidence for Chest CT scan in 
different hospitals in Palestine. 
 
Figure 4.21 shows the high values of breast cancer risk appear in H10, H8, H4 and H7 in 
Palestine hospitals and low values of breast cancer risk in H9, H5 and H1, and these values 
not should exceed the ICRP.  
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The variation related to use different CT scanner manufacture and different scanning 
parameters such as kVp, mAs, rotation time, focal spot size, scan field of view, slice width 
and pitch (Hurwitz et al, 2006) 
On multi slice scanners such as 64 and 128 and single slice scanners such as 16, the 
absorbed radiation dose is inversely proportional to pitch, tube current mA, time product 
and tube potential kV. The dose will be halved if the pitch is doubled. Due to the nature of 
the reconstruction method used, the pitch on single slice scanners the imaged slice width 
increases as the pitch increases, noise on single slice scanner constant with changing pitch, 
and multi slice scanners the imaged slice width to remain constant with pitch. In these 
conditions the noise will increase as the pitch increases (Kalender WA, 2000). 
These factors effect on values organ equivalent dose, and age at exposure for female 
underwent Chest CT scan in ten hospitals in Palestine, (Tokunaga M et al, 2007). 
 
4.10.6 Breast cancer risk assessment for female underwent Chest CT 
scans in Palestine: 
 
The breast cancer risk for female Chest CT scan in Palestine was in younger female is 
0.00042% or 1 in 2645 for a 15 - 39 years and in older female is 0.00014% or 1 in 10,473 
for a 40 - 60 years and these values relatively not high in young and old female in Palestine 
to compare with ICRP is younger female is 0.00865% and in older female is 0.00160%. 
The causes for not should increase breast cancer risk related to breast equivalent doses for 
used CT scanner parameters input on the devices such as CTDIvol and DLP and these 
factors causes reduced lifetime attributable breast cancer risk in different hospitals in 
Palestine. 
The relationship between radiation induced breast cancer risk and radiation dose is a 
product of several factors such as age at exposure, latent period (Time after exposure), 
Hormone level (Tokunaga M et al, 2007). The age of exposure is the most important 
factor, with younger female than those exposed at an older female (UNSCEAR, 2013). The 
reason is a need for estrogen stimulation and tissue proliferation in order for radiation 
damage to occur in breast tissue (Tokunaga M et al, 2007).  
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A brief description of the breast anatomy is provided in Appendix B. The latent period for 
radiation induced breast cancer risk to occur is approximately 5 to 10 years this time is 
longest in younger women and shortest for older women (Ries LAG et al, 2004). The 
others factors in female patients is the breast lies in the perpendicular field of irradiation 
(Andrew J. Einstein et al, 2007). 
The seventh biologic effects of ionizing radiation report (BEIR VII, 2006) "predicts that 
for a standardized U.S. population, these age dependent risks combine to produce an 
average lifetime attributable risk of one radiation induced cancer per 1,000 patients 
receiving a 10 mSv effective dose approximately half of these cancers are expected to be 
fatal" (Richard T. Griffey and Aaron Sodickson, 2009).  
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Chapter Five: 
_______________________________________________________ 
Conclusion and Recommendations: 
 
5.1   Conclusion 
 
This study was an effort to highlight the radiation absorbed doses from CT scan that lead to 
breast cancer risk. The effective dose from chest CT scan per exam varies from 3 to 14.7 
mSv with a mean is 7 mSv, while the breast dose varies from 6.5 to 17.5 mGy per 
procedure, with a mean is 15 mGy. The patient radiation lifetime attributable breast cancer 
risk (LAR) estimated for breast female cancer in Palestine for younger female is 0.00042 
% or 1 in 2645 for a 15 - 39 years and older female is 0.00014 % or 1 in 10,473 for 40 - 60 
years.  
The International commission on radiological protection recommendation (ICRP) the 
breast dose should not exceed 45 mGy, and the lifetime attributable breast cancer risk for 
younger and older female patients should not exceed 0.00865% and 0.00160%, 
respectively.   
The radiation breast dose was not shall high, and the lifetime attributable breast cancer risk 
for younger and older female patients were not should high risk in Palestine. 
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5.2      Recommendations 
 
Identification of breast cancer risk factor and development of radiation protection 
strategies based on CT scan studies can form the basis for developing a comprehensive 
radiation protection strategy to prevent and reduces breast cancer risk from CT scan in 
Palestine. 
 
Based on the study finding, the researcher managed to present the following 
recommendation: 
 
 Radiation dose reduction protocols for Chest from CT scan procedures should be 
used. 
 
 Young patients should be adequately protected in Palestine from radiation risks. 
 
 A large variation of breast organ and effective doses was observed for different 
scanner type, protocols and variation in equipment design. 
 
 CTDIvol and DLP in CT dose parameters that can be universally interpreted. CT 
protocols that specify only kilovolt peak and milliampere second are very poor 
indicators of patient dose. CT protocols should specify both CTDI and DLP. 
 
 Radiographer should review the manufacturer’s preset CTDI and DLP during 
installation of a new CT scanner. Radiographer should also review these data when 
protocol modifications are made. 
 
 The radiation dose used to perform the procedure does not exceed the dose 
necessary to produce an image of adequate diagnostic quality. 
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Appendices  
Appendix A 
Information sheet 
No.     (          )                                                                                           
date............................  
Hospital name................................................................. 
Patient data: 
Gender………………    Height.................. Age................ 
Weight....................kg……………. 
Clinical indications: 
Scan parameter 
Start position.....................  End position…………………….. Kvp ................                     
mAs.............       Pitch..................  Slice thickness.................    Number of 
scan...................... 
Field of view (FOV)............... Total scan time................... Rotation time..........................  
Table feed per rotation............ Displayed………….. CTDIvol...............       
DLP..................... CTDIw....................  
Machine information: 
CT machine manufacture.......................................  
Model Year of installation..................................  
Focal axial distance (FAD).....................  
Detector type.............................................  
Comments.............................. 
        
Figure 1: Types of CT scan 
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Appendix B 
 
BREAST ANATOMY  
The female breast tissue comprised of glandular, fatty and fibrous tissues. They are located 
over the pectorals major muscle and are attached to the sternum. The functional parts of the 
breast include: lobes, lobules, ducts, areola, nipple, fat and blood vessels see Figure 2. 
Each breast is composed of 15-20 lobes, which are arranged in a circular pattern. The lobes 
are made up of smaller lobules which are the milk producing glands. During lactation, 
sensory bulbs located distally on the bulbs respond to hormonal signals from the mother to 
produce breast milk. The ducts are used as passages for the transportation of breast milk 
from glandular tissue to the nipple. Fat covers the spaces between the lobules and ducts. 
During lactation the breast becomes highly lobulated. Newer research in breast anatomy 
has draws the following conclusions about the breast anatomy: 1) glandular tissue is found 
closer to the nipple than previous thought, 65% of the glandular tissue is located within 
30mm from the base of the nipple 2) the ratio of glandular to fat tissue rises to 2:1 in the 
lactating breast, compared to 1:1 ratio in no lactating breast. 
 
Figure 2: shows Anatomy of the female breast 
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Appendix C 
H1 
Table 1: Shows exposure parameters in hospital one in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast 
Dose 
(mGy) 
0 6 6 1 200 425 6.5 13.65 
0 6 6 1 200 425 6.5 13.65 
3 6 6 1 200 422 6.5 13.65 
4 6 6 1 200 422 6.5 13.65 
5 6 6 1 200 422 6.5 13.65 
6 6 6 1 200 425 6.5 13.65 
7 6 6 1 200 422 6.5 13.65 
8 6 6 1 200 422 6.5 13.65 
9 6 6 1 200 422 6.5 13.65 
01 6 6 1 200 425 6.5 13.65 
Mean 6 6 1 200 423 6.5 13.65 
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H2 
Table 2: Shows exposure parameters in hospital tow in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 8 8 1 200 410 5.5 11 
0 8 8 1 200 410 6.5 15 
3 8 8 1 200 410 6.5 15 
4 8 8 1 200 410 5 11 
5 8 8 1 200 410 6.5 15 
6 8 8 1 200 410 5 11 
7 8 8 1 200 410 6.5 15 
8 8 8 1 200 410 5 11 
9 8 8 1 200 410 6.5 15 
01 8 8 1 200 410 5 11 
11 8 8 1 200 410 6.5 15 
12 8 8 1 200 410 5 11 
13 8 8 1 200 410 6.5 15 
14 8 8 1 200 410 5 11 
15 8 8 1 200 410 6.5 15 
Mean 8 8 1 200 410 7 13 
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H3 
Table 3: Shows exposure parameters in hospital three in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 8 8 1 220 410 7.5 15 
0 8 8 1 220 410 7.5 15 
3 7 7 1 210 410 6.5 13 
4 7 7 1 220 410 6 12.5 
5 8 8 1 220 410 7.7 15.5 
6 8 8 1 220 410 12.5 15 
7 9 9 1 210 410 6.5 13 
8 7 7 1 210 410 6 12.5 
9 8 8 1 220 410 7.7 15.5 
01 8 8 1 220 410 7.5 15 
11 8 8 1 210 410 6.5 13 
12 7 7 1 210 410 6 12.5 
13 8 8 1 220 410 7.7 15.5 
14 8 8 1 220 410 7.5 15 
15 7 7 1 210 410 6.5 13 
Mean 7.7 7.7 1 216 410 8 14 
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H4 
Table 4: Shows exposure parameters in hospital four in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 10 9 0.9 300 976 8 20 
0 11 10 0.9 300 980 9 22 
3 12.5 11 0.9 300 976 8 20 
4 11.5 10 0.9 300 980 10 25 
5 10 9 0.9 300 976 8 20 
6 11 10 0.9 300 980 10 25 
7 10 9 0.9 300 976 9 20 
8 11 10 0.9 300 980 10 25 
9 12.5 11 0.9 300 976 8 20 
01 11.5 10 0.9 300 980 10 25 
11 10 9 0.9 300 976 9 20 
12 11 10 0.9 300 980 9 25 
13 10 9 0.9 300 976 8 20 
14 11 10 0.9 300 980 8 20 
15 12.5 11 0.9 300 976 8 20 
16 10 9 0.9 300 980 9 22 
17 11 10 0.9 300 980 10 25 
18 12.5 12.5 0.9 300 976 8 20 
19 11.5 10 0.9 300 980 10 25 
20 10 9 0.9 300 976 8 20 
21 11 10 0.9 300 980 10 25 
22 10 9 0.9 300 976 8 20 
23 11 10 0.9 300 980 10 25 
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24 12.5 11 0.9 300 976 8 20 
25 11.5 10 0.9 300 980 8 20 
26 10 9 0.9 300 976 8 20 
27 11 10 0.9 300 980 10 25 
28 10 9 0.9 300 980 8 20 
29 11 10 0.9 300 976 8 20 
30 12.5 11 0.9 300 980 8 20 
Mean 11 10 0.9 300 976 8.8 22 
 
 
H5 
Table 5: Shows exposure parameters in hospital five in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 6 5.4 0.9 
155 
450 5 10 
0 13 11 0.9 
197 
450 6 11 
3 5 4.5 0.9 
190 
430 4 8 
4 5 4.5 0.9 
197 
450 6 11 
5 4 3.6 0.9 
190 
430 4 6 
6 13 11 0.9 
150 
430 5 9 
7 5 4.5 0.9 
190 
430 5 9 
8 5 4.5 0.9 
150 
430 4 8 
9 10 9 0.9 
190 
430 5 9 
01 6 5.4 0.9 
150 
430 5 8 
11 4 3.6 0.9 
190 
450 4 7 
12 6 5.4 0.9 
150 
400 5 8 
13 5 4.5 0.9 
150 
430 4 8 
14 5 4.5 0.9 
197 
430 5 9 
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15 4 3.6 0.9 
150 
400 4 8 
16 4 3.6 0.9 
150 
430 4 9 
17 5 4.5 0.9 
150 
400 4 8 
18 6 5.4 0.9 
197 
450 6 11 
19 5 4.5 0.9 
150 
400 4 8 
20 4 3.6 0.9 
190 
400 4 8 
21 5 4.5 0.9 
197 
430 5 9 
22 6 5.4 0.9 
150 
430 5 8 
23 5 4.5 0.9 
190 
430 5 9 
24 4 3.6 0.9 
190 
430 4 8 
25 6 5.4 0.9 
150 
430 6 11 
26 5 4.5 0.9 
150 
430 4 8 
27 5 4.5 0.9 
150 
400 4 8 
28 4 3.6 0.9 
150 
430 4 9 
29 5 4.5 0.9 
150 
430 4 8 
30 5 4.5 0.9 
150 
430 5 9 
Mean 5.6 5 0.9 
168 
427 4.6 8.6 
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Table 6: Shows exposure parameters in hospital six in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 6 6 1 200 400 6 14 
0 5 5 1 200 380 5 9 
3 8 8 1 200 400 6 14 
4 6 6 1 200 400 6 14 
5 8 8 1 200 400 4 9 
6 6 6 1 200 400 6 14 
7 8 8 1 200 400 4 9 
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8 6 6 1 200 400 6 14 
9 6.4 6.4 1 200 420 6 14 
01 5 5 1 200 400 4 9 
11 6.4 6.4 1 200 420 6 14 
12 6 6 1 200 400 6 14 
13 6.4 6.4 1 200 420 6 14 
14 5 5 1 200 400 5 12 
15 6.4 6.4 1 200 420 6 14 
16 6 6 1 200 420 6 14 
17 5 5 1 200 400 4 9 
18 6 6 1 200 420 6 14 
19 6 6 1 200 420 6 14 
20 5 5 1 200 400 4 9 
Mean 6 6 1 200 406 5.4 12.4 
 
H7 
Table 7: Shows exposure parameters in hospital seven in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 8.5 7.6 0.9 245 1000 8 16 
0 7.5 6.7 0.9 240 950 6.5 15 
3 7.5 6.7 0.9 245 950 6.5 15 
4 8.5 7.6 0.9 245 1000 8 16 
5 7.5 6.7 0.9 240 950 6.5 15 
6 8.5 7.6 0.9 245 1000 8 16 
7 7.5 6.7 0.9 240 950 6.5 15 
8 7.5 6.7 0.9 240 950 6.5 15 
9 8.5 7.6 0.9 245 980 8 16 
01 7.5 6.7 0.9 240 950 6.5 15 
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11 7.5 6.7 0.9 245 950 6.5 15 
12 8.5 7.6 0.9 240 1000 8 16 
13 7.5 6.7 0.9 245 950 6.5 15 
14 8.5 7.6 0.9 240 1000 8 16 
15 7.5 6.7 0.9 240 970 6.5 15 
16 8.5 7.6 0.9 245 950 8 16 
17 7.5 6.7 0.9 240 950 6.5 15 
18 8.5 7.6 0.9 245 1000 8 16 
19 7.5 6.7 0.9 240 950 6.5 15 
20 8.5 7.6 0.9 240 950 8 16 
Mean 8 7 0.9 240 967 7 15.4 
 
H8 
Table 8: Shows exposure parameters in hospital eight in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 15 13.5 0.9 250 1000 14.7 28 
0 15 13.5 0.9 250 1000 14.7 28 
3 15 13.5 0.9 250 1000 14.7 28 
4 15 13.5 0.9 250 1000 14.7 28 
5 15 13.5 0.9 250 1000 14.7 28 
6 15 13.5 0.9 250 1000 14.7 28 
7 15 13.5 0.9 250 1000 14.7 28 
8 15 13.5 0.9 250 1000 14.7 28 
9 15 13.5 0.9 250 1000 14.7 28 
01 15 13.5 0.9 250 1000 14.7 28 
11 15 13.5 0.9 250 1000 14.7 28 
12 15 13.5 0.9 250 1000 14.7 28 
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13 15 13.5 0.9 250 1000 14.7 28 
14 15 13.5 0.9 250 1000 14.7 28 
15 15 13.5 0.9 250 1000 14.7 28 
16 15 13.5 0.9 250 1000 14.7 28 
17 15 13.5 0.9 250 1000 14.7 28 
18 15 13.5 0.9 250 1000 14.7 28 
19 15 13.5 0.9 250 1000 14.7 28 
20 15 13.5 0.9 250 1000 14.7 28 
Mean 15 13.5 0.9 250 1000 14.7 28 
 
 
H9 
Table 9: Shows exposure parameters in hospital nine in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 5 5 1 200 420 3 6.5 
0 4 4 1 200 420 3 6.5 
3 3 3 1 200 400 3 6.5 
4 5 5 1 200 420 3 6.5 
5 4 4 1 200 400 3 6.5 
6 3 3 1 200 400 3 6.5 
7 5 5 1 200 420 3 6.5 
8 4 4 1 200 400 3 6.5 
9 3 3 1 200 420 3 6.5 
01 4 4 1 200 420 3 6.5 
11 4 4 1 200 400 3 6.5 
12 3 3 1 200 400 3 6.5 
13 3 3 1 200 400 3 6.5 
14 4 4 1 200 420 3 6.5 
15 4 4 1 200 400 3 6.5 
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16 3 3 1 200 400 3 6.5 
17 4 4 1 200 400 3 6.5 
18 3 3 1 200 400 3 6.5 
19 3 3 1 200 400 3 6.5 
20 4 4 1 200 400 3 6.5 
Mean 3.75 3.75 1 200 407 3 6.5 
 
H10 
Table 10: Shows exposure parameters in hospital ten in Palestine 
Patients 
number 
CTDIVOL 
(mGy) 
Per 100 mAs 
CTDIw 
(mGy) = 
CTDIVOL x 
Pitch 
 
Pitch mAs DLP   
(mGy.cm) 
Effective 
dose  (mSv) 
Breast Dose 
(mGy) 
0 16 14.4 0.9 350 1000 8 16 
0 17 15.3 0.9 350 1100 9 19 
3 16 14.4 0.9 350 1100 8 16 
4 16 14.4 0.9 350 1000 9 19 
5 17 15.3 0.9 350 1100 8 16 
6 17 15.3 0.9 350 1000 9 19 
7 16 14.4 0.9 350 1100 8 16 
8 17 15.3 0.9 350 1100 9 19 
9 16 14.4 0.9 350 1100 8 16 
01 17 15.3 0.9 350 1000 9 19 
11 16 14.4 0.9 350 1100 8 16 
12 17 15.3 0.9 350 1100 9 19 
13 16 14.4 0.9 350 1000 8 16 
14 17 15.3 0.9 350 1100 9 19 
15 16 14.4 0.9 350 1100 8 16 
16 17 15.3 0.9 350 1000 9 19 
17 16 14.4 0.9 350 1100 8 16 
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18 17 15.3 0.9 350 1100 9 19 
19 16 14.4 0.9 350 1000 8 16 
20 17 15.3 0.9 350 1100 9 19 
Mean 16.6 14.8 0.9 350 1067 8.5 17.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
104 
 
Appendix D 
H1 
Table 1: Shows Lifetime attributable breast cancer risk of age Patients in hospital one in Palestine 
Patients number Age 
 (Y) 
Breast  equivalent dose 
(mSv) 
lifetime attributable risk 
(LAR)   
 % 
0 65 14   0.00003 % 
1 in 33333 
0 32 14   0.0003 % 
1 in 3125 
3 60 14 0.000043 % 
1 in 23,255 
4 40 14 0.0002 % 
1 in 5066 
5 50 14 0.0001 % 
1 in 10,204 
6 45 14 0.00015 % 
1 in 6757 
7 34 14 0.00028 % 
1 in 3571 
8 66 14 0.000028 % 
1 in 35,714 
9 38 14 0.00023 % 
1 in 9276 
01 70 14 0.0000168 % 
1 in 59,532 
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H2 
Table 2: Shows Lifetime attributable breast cancer risk of age Patients in hospital two in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
1 55 11 0.000055 % 
1 in 18,018 
0 45 15 0.00016 % 
1 in 6329 
3 32 15 0.000345 % 
1 in 2828.5 
4 28 11 0.000319 % 
1 in 3135 
5 30 15 0.00034 % 
1 in 2632 
6 66 11 0.000022 % 
1 in 45,454 
7 22 15 0.000585 % 
1 in 1709 
8 44 11 0.00012 % 
1 in 8333 
9 24 15 0.000525 % 
1 in 1905 
01 52 11 0.00007 % 
1 in 14,705 
00 60 15 0.0000465 % 
1 in 21,505 
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00 45 11 0.000116 % 
1 in 8621 
03 30 15 0.00038 % 
1 in 2632 
04 44 11 0.00012 % 
1 in 8130 
05 32 15 0.000345 % 
1 in 2899 
 
 
 
H3 
Table 3: Shows Lifetime attributable breast cancer risk of age Patients in hospital three in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
1 75 15 0.000012 % 
1 in 83.333 
0 65 15 0.000032 % 
1 in 52,631 
3 45 13 0.00014 % 
1 in 7299 
4 30 12.5 0.000316 % 
1 in 3165 
5 34 15.5 0.00031 % 
1 in 3226 
6 54 15 0.00008 % 
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1 in 12,500 
7 33 13 0.00028 % 
1 in 3571 
8 62 12.5 0.000034 % 
1 in 29,412 
9 22 15.5 0.0006 % 
1 in 1667 
01 50 15 0.0001 % 
1 in 9524 
00 30 13 0.00033 % 
1 in 3030 
00 33 12.5 0.00027 % 
1 in 3703 
03 52 15.5 0.0001 % 
1 in 10,526 
04 46 15 0.00016 % 
1 in 6250 
05 32 13 0.0003 % 
1 in 3333 
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H4 
Table 4: Shows Lifetime attributable breast cancer risk of age Patients in hospital four in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 68 20 0.000034 % 
1 in 29,411 
0 65 22 0.00005 % 
1 in 21,277 
3 40 20 0.0003 % 
1 in 4762 
4 45 25  0.00026 % 
1 in 3846 
5 24 20 0.0007 % 
1 in 1429 
6 35 25 0.0004 % 
1 in 2041 
7 37 20 0.00033 % 
1 in 3067 
8 62 25 0.00007 % 
1 in 14,286 
9 27 20 0.0006 % 
1 in 1667 
01 44 25 0.0003 % 
1 in 3571 
00 35 20 0.0004 % 
1 in 2564 
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00 34 25 0.0005 % 
1 in 2000 
03 32 20 0.00046 % 
1 in 2174 
04 54 20 0.00011 % 
1 in 9091 
05 26 20 0.00062 % 
1 in 1613 
06 24 22 0.00077 % 
1 in 1300 
07 52 25 0.00016 % 
1 in 6452 
08 60 20 0.00006 % 
1 in 16,667 
09 45 25 0.00026 % 
1 in 3846 
01 30 20 0.0005 % 
1 in 1976 
00 44 25 0.0003 % 
1 in 3571 
00 32 20 0.00046 % 
1 in 2174 
03 60 25 0.00008 % 
1 in 12,500 
04 65 20 0.00004 % 
1 in 25.000 
05 32 20 0.00046 % 
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1 in 2174 
06 60 20 0.00006 % 
1 in 16,667 
07 40 25 0.00035 % 
1 in 2857 
08 50 20 0.00014 % 
1 in 7143 
09 45 20 0.0002 % 
1 in 4762 
31 34 20 0.0004 % 
1 in 2500 
 
 
H5 
Table 5: Shows Lifetime attributable breast cancer risk of cancer incidence age Patients in hospital five in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 72 10 0.000011 % 
1 in 90,909 
0 60 11 0.000034 % 
1 in 29.411 
3 60 8 0.000025 % 
1 in 40,000 
4 55 11   0.000056 % 
1 in 18,189 
5 45 6 0.00006 % 
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1 in 16,667 
6 54 9 0.00005 % 
1 in 20.000 
7 36 9 0.00017 % 
1 in 5882 
8 22 8 0.0003 % 
1 in 3226 
9 50 9 0.00006 % 
1 in 16,667 
01 30 8 0.0002 % 
1 in 5000 
00 33 7 0.00015 % 
1 in 6494 
00 52 8 0.00005 % 
1 in 20,000 
03 46 8 0.00009 % 
1 in 11,111 
04 32 9 0.0002 % 
1 in 4762 
05 27 8 0.00023 % 
1 in 4167 
06 38 9   0.00015 % 
1 in 6667 
07 24 8 0.00028 % 
1 in 3571 
08 60 11 0.000034 % 
1 in 29,411 
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09 42 8 0.0001 % 
1 in 10,000 
01 66 8 0.000015 % 
1 in 66,667 
00 55 9 0.000045 % 
1 in 22,222 
00 40 8 0.00011 % 
1 in 9091 
03 35 9 0.00017 % 
1 in 5650 
04 34 8 0.00016 % 
1 in 6250 
05 32 11 0.00025 % 
1 in 4000 
06 54 8 0.000044 % 
1 in 22727 
07 26 8 0.00025 % 
1 in 4000 
08 24 9 0.0003 % 
1 in 3175 
09 52 8 0.00005 % 
1 in 20.000 
31 60 9   0.000028 % 
1 in 33,333 
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H6 
 
Table 6: Shows Lifetime attributable breast cancer risk of age Patients in hospital six in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 72 14 0.000014 % 
1 in 66,667 
0 60 9 0.00003 % 
1 in 33,333 
3 60 14 0.000043 % 
1 in 23,256 
4 55 14 0.00007 % 
1 in 14,286 
5 45 9 0.000095 % 
1 in 10,526 
6 54 14 0.000077 % 
1 in 12,987 
7 36 9 0.00017 % 
1 in 5882 
8 22 14 0.00055 % 
1 in 1818 
9 50 14 0.00007 % 
1 in 10,204 
01 30 9 0.00023 % 
1 in 4348 
00 33 14 0.00031 % 
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1 in 3226 
00 52 14 0.000087 % 
1 in 11,494 
03 46 14 0.00015 % 
1 in 6667 
04 32 12 0.00028 % 
1 in 3636 
05 27 14 0.0004 % 
1 in 2326 
06 38 14 0.00023 % 
1 in 4349 
07 24 9 0.0003 % 
1 in 3175 
08 60 14 0.00004 % 
1 in 25,000 
09 42 14 0.00018 % 
1 in 1778 
01 66 9 0.000017 % 
1 in 58824 
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H7 
 
Table 7: Shows Lifetime attributable breast cancer risk of age Patients in hospital seven in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 38 16 0.00026 % 
1 in 3774 
0 60 15 0.00005 % 
1 in 20,000 
3 55 15 0.000076 % 
1 in 13,158 
4 26 16 0.0005 % 
1 in 2000 
5 60 15 0.000046 % 
1 in 21739 
6 25 16 0.00055 % 
1 in 1818 
7 62 15 0.00004 % 
1 in 25,000 
8 26 15 0.00047 % 
1 in 2151 
9 24 16 0.00056 % 
1 in 1786 
01 50 15 0.0001 % 
1 in 9524 
00 60 15 0.000047 % 
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1 in 21,739 
00 38 16   0.00026 % 
1 in 3788 
03 28 15 0.00044 % 
1 in 2300 
04 45 16 0.00017 % 
1 in 5882 
05 51 15 0.0001 % 
1 in 10,000 
06 27 16 0.0005 % 
1 in 2083 
07 38 15 0.00025 % 
1 in 4000 
08 24 16 0.00056 % 
1 in 1786 
09 60 15 0.00005 % 
1 in 21,739 
01 42 16 0.0002 % 
1 in 5000 
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H8 
Table 8: Shows Lifetime attributable breast cancer risk of age Patients in hospital eight in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 36 28 0.0005 % 
1 in 1887 
0 60 28 0.00009 % 
1 in 11,111 
3 35 28 0.00055 % 
1 in 1818 
4 40 28 0.0004 % 
1 in 2564 
5 65 28 0.00006 % 
1 in 16,667 
6 27 28 0.0008 % 
1 in 1205 
7 55 28 0.00014 % 
1 in 7143 
8 35 28 0.00055 % 
1 in 1818 
9 26 28 0.0009 % 
1 in 1149 
01 48 28 0.0002 % 
1 in 4255 
00 43 28 0.00034 % 
1 in 2941 
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00 17 28 0.0014 % 
1 in 725 
03 53 28 0.00016 % 
1 in 6250 
04 32 28 0.0006 % 
1 in 1563 
05 18 28 0.00136 % 
1 in 735 
06 36 28 0.0005 % 
1 in 752 
07 55 28 0.00014 % 
1 in 7142 
08 35 28 0.00055 % 
1 in 1818 
09 26 28 0.0009 % 
1 in 1111 
01 48 28 0.00023 % 
1 in 4255 
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H9 
Table 9: Shows Lifetime attributable breast cancer risk of age Patients in hospital nine in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 75 6.5 0.000008 % 
1 in 200,000 
0 28 6.5 0.00019 % 
1 in 5263 
3 52 6.5 0.00004 % 
1 in 25,000 
4 19 6.5 0.0003 % 
1 in 3571 
5 55 6.5 0.00003 % 
1 in 33,333 
6 32 6.5 0.00015 % 
1 in 6667 
7 63 6.5 0.000017 % 
1 in 50,000 
8 44 6.5 0.00007 % 
1 in 14,286 
9 60 6.5 0.00002 % 
1 in 50,000 
01 36 6.5 0.0001 % 
1 in 8333 
00 65 6.5 0.000014 % 
1 in 71,429 
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00 23 6.5 0.00023 % 
1 in 4267 
03 37 6.5 0.00011 % 
1 in 9090 
04 33 6.5 0.00014 % 
1 in 7143 
05 52 6.5 0.00004 % 
1 in 25,000 
06 46 6.5 0.00007 % 
1 in 14,286 
07 32 6.5 0.00015 % 
1 in 6667 
08 27 6.5 0.0002 % 
1 in 5263 
09 38 6.5 0.0001 % 
1 in 9346 
01 24 6.5 0.00022 % 
1 in 4444 
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H10 
Table 10: Shows Lifetime attributable breast cancer risk of age Patients in hospital ten in Palestine. 
Patients number Age 
 (Y) 
Breast organ equivalent 
dose 
(mSv) 
lifetime attributable risk 
(LAR) 
% 
0 45 16 0.00017 % 
1 in 5882 
0 30 19 0.0005 % 
1 in 2083 
3 22 16 0.0006 % 
1 in 1613 
4 60 19 0.00006 % 
1 in 16,667 
5 40 16 0.00022 % 
1 in 4444 
6 18 19 0.0009 % 
1 in 1087 
7 28 16 0.00046 % 
1 in 2174 
8 43 19 0.00023 % 
1 in 4348 
9 55 16 0.00008 % 
1 in 20,000 
01 31 19 0.00044 % 
1 in 2222 
00 20 16 0.0007 % 
1 in 1449 
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00 28 19 0.00055 % 
1 in 1818 
03 42 16 0.0002 % 
1 in 5000 
04 50 19 0.00013 % 
1 in 7692 
05 24 16 0.00056 % 
1 in 1786 
06 55 19 0.0001 % 
1 in 10,000 
07 32 16 0.0004 % 
1 in 2703 
08 63 19 0.00005 % 
1 in 20,000 
09 44 16 0.00017 % 
1 in 5714 
01 60 19 0.00006 % 
1 in 16,667 
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 الجرعة الاشعاعية لمثدي ومخاطر الإصابة بالسرطان لدى الإناث نتيجة التصوير الطبقي المقطعي
 في فمسطين
 عداد: صالح احمد صالح كميلإ
 مشرف: د.عدنان المحامال
  : ممخصال
استخدام التصوير المقطعي في التشخيص الطبي يعطي جرعات إشعاعية لممرضى أعمى من جرعات  
قميدي. ويمكن أن يشكل سوء استخدام  البروتوكولات الى زيادة جرعة الإشعاع التصوير الطبي الت
٪ من إجمالي الإجراءات الطبية الأشعة السينية التي  20لممرضى. الأشعة المقطعية تمثل حوالي 
 أجريت في جميع أنحاء العالم. الصورة المقطعية لمصدر هي واحدة من الإجراءات الأكثر شيوعا. 
في  2منها في الضفة الغربية و  20جهاز طبقي مقطعي ،  20يوجد حاليا حوالي في فمسطين ، 
قطاع غزة. في حالة مرضى الإناث ، تقدم الصورة المقطعية لمصدر جرعة عالية لمثدي إلى حد كبير 
لحساسية  للاشعة. ويهدف هذا العمل إلى تقييم جرعة الثدي ومدة الحياة المرتبطة بخطر التعرض 
 مستشفيات في فمسطين ، الضفة الغربية وقطاع غزة. 20مريضة في  220مى الذي أجري ع
تم إجراء تقدير الجرعة نظريا باستخدام البرمجيات المتاحة تجاريا عمى أساس محاكاة مونتي كارلو 
لجسم الإنسان مع الأنسجة التى تحاكي جسم الأنسان لجميع الأعمار والأحجام. وتم استخدم نموذج 
لتقييم دقيق لمخاطر السرطان لجرعة العضو النسيجي الداخمي المرتبطة  0لمرحمة بير سبعة من ا
 بالعمر.
تم جمع جميع البيانات المدخمة ذات الصمة في قاعدة البيانات بما في ذلك بيانات المريض مثل العمر 
 والوزن ومؤشر كتمة الجسم ، وبيانات عن اجهزة التصوير المقطعي مثل مؤشر التصوير المقطعي
المحوسب ، طول الجرعة  المنتجة ، التيار الكهربائي لمتيوب ، وفرق الجهد. ووجد أن الجرعة 
الإشعاعية الناتجة عن نفس الاختبار تختمف اختلافا كبيرا بين المستشفيات اعتمادا عمى المعايير 
 المستخدمة ونوع الجهاز المقطعي.
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ممي سيفرت  1.20إلى  3تبار تختمف من بالنسبة لجميع المرضى، الجرعة الفعالة لمصدر لكل اخ
 6.10إلى  6.5ممي سيفرت لكل إجراء ، في حين أن جرعة الثدي تختمف من  1 هوومع متوسط 
ممي جراي. وكان معدل التعرض للإصابة بسرطان الثدي  60 هوممي جراي لكل إجراء، مع متوسط 
 6250في  0٪ أو 02222.2سنا هو  المرتبط بالعمر لدى الإناث في فمسطين ، في الإناث الاصغر
من عمر  312.20في  0٪ أو 20222.2سنة وعند الإناث الاكبر سنا هو  33 -60من عمر 
سنة، وأوصت المجنة الدولية لموقاية من الأشعاع أن لا تتجاوز الجرعة الأشعاعية لمثدي من  25-22
رض للإصابة بسرطان الثدي ممي جراي ، وأن لا يتجاوز معدل التع 62التصوير المقطعي لمصدرهو 
% ، 2502262% ، 65222.2المرتبط بالعمر لدى الإناث الاصغر سنا والإناث الاكبر سنا هو 
 عمى التوالي. 
تشير النتائج إلى أن الجرعة الإشعاعية للأنسجة الثدي الغدية تنخفض عموما مع استخدام المعايير 
 المناسبة لمتعرض الأشعاعي.
